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Abstract
This dissertation covers two projects linked by their involvement in the modification of
tRNA bases.

The first project focused on an investigation of a role for the modified base Archaeosine,
the ubiquitous modification in tRNA in the archaeal domain. Initial work was performed
on a set of in vitro prepared tRNA modified to feature either the canonical guanine base at
position 15, preQ0 (TGT product) or Archaeosine (ArcS product). There was very little
difference in the thermal stability of tRNAs containing these modifications in the halophilic
H. volcanii tRNASer or E. coli tRNAGln. In tRNAGln taken from M. thermautotrophicum
however, there was a 2°C increase in melting point in 50 mM MgCl2 upon modification to
archaeosoine.

Benefitting from the development of genetic tools for the generation of specific deletion
mutants of the thermophile Thermococcus kodakarensis, it was possible to start
investigation of tRNAs that have been hypomodified in vivo due to the lack of arcTGT
(TK0760) and ArcS (TK2156). In vitro modified equivalents of the GlnCUG isoacceptor
were also prepared. Thermal stability of these tRNAs show virtually identical melting
transitions, with a biphasic denaturation occurring at all magnesium concentrations tested.
Isolation of the CUG isoacceptor from the in vivo maturated total tRNA pool allowed melts
of specifically hypomodified tRNAs. Those containg Archaeosine (WT) and genetically
encoded guanine (∆tgt) showed identical melting profiles with Tm beyond the 98°C limit
i

of the experiment. In the preQ0 containing in vivo RNA the shows a lag in its magnesium
response, and a more persistent biphasic melting profile. At 10mM Mg2+ concentration the
preQ0 containing tRNA is approaching a Tm of 98°C though the turn over point in the melt
is not well defined.

The second project was to investigate the product of base treatment of the oxidized cofactor
NAD(P)+. This cofactor is involved in the biosynthesis of preQ1 from preQ0 in bacterial
systems and at low concentrations it can be difficult to quantify enzyme activity based on
direct quantitation. Under these conditions a fluorescence based method where by the
production of NAD(P)+ is measured rather than the consumption of NAD(P)H.

Base treatment of the oxidized cofactor generates a fluorescent species with an efficiency
of 95%. The assay has been used extensively by our group to track activity of various
enzymes including QueF, however the identity of the fluorophore had not been established.
Purification of the fluorescent product was achieved by isocratic HPLC in water using a
reverse phase column. It was found that the assay conditions previously used (7.5M NaOH
for 2 hours) wer actually counterproductive for maximizing fluorescence yield. Incubation
at 2M NaOH gave a 35% increase in product yield. The isolated product was determined
to have molecular weight of 123.0318 (3.6 ppm by accurate mass ESI MS). 1H and 13C
NMR were used to confirm the structure to be that of 2-hydroxynicotinaldeyde. It was also
possible to determine the quantum yield for the molecule to 0.11. Work carried out
previously on pyridinium based NADP analogs is consistent with the identity of the
fluorophore presented here.
ii
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Introduction

The metabolism of nucleic acids is integrated into most regulatory steps of cell
proliferation. The process of synthesizing, maintaining and recycling RNA in particular is
both highly dynamic and sensitive to the external conditions of the cell. In order to maintain
viability under the vast range of condition under which life can persist, strategies capable
of adapting fundamental processes such as DNA replication and gene expression have
evolved. The archaea are particularly abundant in extreme environments of temperature,
pH and osmotic potential. Modification of archaeal RNAs and the enzymes involved
therein have been a source of unique biological chemistries. Here we study the effects of
one such modification, archaeosine, found exclusively in the archaea. We also examine the
pyridine nucleotide cofactors NADH and the phosphorylated NADPH which are utilized
in the biosynthetic pathways involved in RNA metabolism, including base modification.

Transfer RNA

Structure and primary function
Transfer RNA, or tRNA, has evolved to serve as the adaptor molecule in converting a
nucleic acid based genetic code into an amino acid sequence of a protein gene product. The
amino acid to be incorporated into the growing polypeptide is selected for by specific
charging of a particular tRNA by an aminoacyl tRNA synthetase. The aminoacyl tRNA
(aa-tRNA) product of this reaction is then carried into the translation machinery where it
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is held to facilitate the transfer of the amino acid from the 3’ end of the tRNA onto the Cterminus of the growing protein product.

Interactions between macromolecules in the translation process require multiple assembly
steps and dynamic contacts. This makes sequence and structure of a given tRNA molecule
crucial. Identifiers that ensure the maintenance of fidelity derive from not only nucleotide
sequence but also from the correct placement of those nucleotides in space.

Unlike DNA, which is most often found in stable, double stranded form (where every base
has a maintained cognate pair), RNA is more likely to be found as a single stranded
polymer. This promotes a collapse into a range of more complex secondary and tertiary
structures that are grouped into well-defined motifs, often utilizing non-Watson-Crick base
pairing 1, 2. Helical regions dominate the modes of interaction, but are punctuated by singlestranded regions, permitting high degrees of flexibility

3, 4

. Inter-helical and loop-loop

interactions allow for further stabilization and longer-range contacts 5.

tRNA molecules range from 70-95 bases in length 6, 7. Although there are a large number
of codons that must be accounted for by the tRNA molecules, the nature of the interactions
within the ribosome means that they must all adopt a very similar general folded structure.
The secondary structure of most tRNAs includes four helical regions, allowing tRNA to be
represented by a cloverleaf diagram when portraying 2° structural contacts (Figure 1.1a).
The stems are referred to as the acceptor stem (comprised of the 5’ and 3’ terminal residues
and hence the position at which the amino acid is attached during charging), the
2

dihydrouridine stem (named for the conserved modification of uridine to the dihydroderivative), the anti-codon stem (the loop formed by this stem contains the 3 base anticodon which base pairs with the codon found in mRNA during translation) and finally the
TΨC stem (featuring the conserved base modification of pseudouridine). As well as these
stemloop structures, there is a variable loop which often has no predicted secondary
structure contacts, but facilitates the formation of tertiary contacts at the core of the tRNA.

Coaxial stacking of the acceptor stem upon the TΨC stem, and dihydrouridine stem upon
the anti-codon stem, respectively, initiates the native fold of tRNA. Further rearrangement
allows these to form the now extensively studied L-form structure of fully folded tRNA
associated with normal function (Figure 1.1b).

Secondary roles
Though the function of tRNA described here is well characterized, alternative roles for
these molecules is a significant field in its own right. Regulation of gene expression through
control of transcription and translation initiation and processivity have been shown to be
dependent on tRNA through numerous mechanisms.

The T box riboswitch is utilized by Gram-positive bacteria in the 5’ UTR to sense levels
of aa-tRNA, and so regulating the expression of tRNA synthetase genes based on product
levels. This occurs via differential binding to the riboswitch aptamer and effecter regions
depending on the presence or absence of the amino acylated tRNA8. During active
translation, occurrences of mis-incorporation will often lead to stalling of the ribosome. It
3

has been shown that a family of tRNA related molecules (tmRNA) are involved in the
rescue of the stalled complex, and tagging the incorrectly formed peptide for degradation9.

Cleavage of tRNA under oxidative stress and nutritional deprivation induces the production
of fragments (cleavage occurs predominantly in the ASL but also in the D-loop and
variable loops). These fragments signal various forms of stress response, shutting down
proliferation by blocking translation machinery and inducing mRNA degradation by the
RISC complex and RNaseZ activity 10. tRNA fragments appear to be utilized to halt cell
growth, but have also been shown to stimulate proliferation. Indeed, tRNA derived
fragments were found to make up a significant population (40%) of small RNAs in a
prostate cancer cell line 11.

In a process reminiscent of the role of tRNAs is translation, tRNA dependent
aminoacylation of phospholipid phosphotidylglycerol occurs at the cell membrane of
bacteria. The enzyme aa-PGS catalyses the transfer of the amino acid group from the 3’
terminus of alanyl-, lysyl-, arginyl- and ornithyl-tRNA to the glycerol group of a
phospholipid. These modifications alter the overall charge of the membrane surface,
reducing the susceptibility of the bacterium to Cationic Anti-Microbial Peptides 12, 13. It is
clear that in all of these roles, the structures adopted by not only intact tRNA but also by
tRNA fragments are crucial for correct cellular functions and cell cycle events to be
maintained.
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Nucleotide modification in tRNA

When considering the structure of tRNA and its function, it is important to appreciate the
extent to which tRNA molecules are modified to contain non-genetically encoded
nucleotides. Variable degrees of modification occur within different tRNAs but they are
on the whole the richest source of modified bases of any class of RNA, with a significant
number of bases in each RNA being modified in vivo. These changes extend the types of
interaction that may occur and so can modulate both the structure and function of a mature
RNA compared to the unmodified counterpart.

Of the 109 naturally occurring nucleotide modifications currently identified, 92 of these
are found in the tRNA pool14, and any given tRNA has 10-25% of the genetically encoded
nucleotides modified7, 15. The degree to which a given base is modified varies greatly.
Simple modifications such as methylation and the U to Y isomerisation are often directed
by the action of a single enzyme16, the substrate nucleotide being defined by its position
within the tRNA structure. This is also often the case for N-methylation of the four
genetically encoded bases that are so modified. O-methylation (Figure 1.2) occurring on
the ribose moiety will more often occur in a multi-protein/guide RNA complex (also the
case in the Cbf5 family of y-synthases)17. The guide RNA will base pair with the RNA to
be modified and the enzyme binds to the complex in a manner that places it in close
proximity of the substrate nucleotide.

5

More complex modifications require multiple enzymatic steps to produce the final
biologically relevant modification. The 7-deazaguanosine modified nucleosides
archaeosine and queuosine (discussed below) are prime examples of the potential
complexity of both the biosynthetic pathways and the biological function of tRNA
modification.

Roles for these modifications in tRNA vary greatly and indeed most are still unknown. Of
those characterized, there is a significant number occurring in the ASL, with both the
wobble position 34 and position 37 being particular hotspots. Since there is such an
important role for the wobble position in successful translation and in the regulation
thereof, it is not surprising that many modifications have evolved that relate to correct
presentation of the anticodon loop to the translation machinery.

One of the only universally conserved modifications occurring in the ACL is N6threonylcarbamoyladenosine (t6A)18 (Figure 1.2) which is located at position 37 . It is
produced in all domains of life in a multi-enzyme biosynthetic pathway that has recently
been elucidated19. Already a complex modification it can be further derivatized to the 2methylthio form20, 21. Both of these can in turn be cyclized to increase the complexity of
the modification22.

The biosynthesis begins with the formation of threonyl-carbamoyl AMP, from CO2/HCO3,
ATP

and

threonine

by

TsaC/TsaC2

(bacteria)
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or

Tsc1/Tcs2

(archaea

and

eukaryotes)23. TsaB TsaD and TsaE (or their homologs) will then transfer the threonylcarbomyl moiety specifically on to ANN decoding tRNA in an ATP driven reaction24.

The role of the modification itself was elucidated by structural studies of the isolated anticodon loop25. The structure of the base in the stem loop adopts a conformation that sets up
an effective third heterocycle, stabilized by an internal H-bond between N1 and N11.
The threonyl moiety remains relatively unstructured but the added bulk rotates the adenine
ring out of range from predicted stacking interactions with U36. Instead of this interaction,
it forms cross strand stacking with A1 of the codon it is set to decode.

7-methylguanine (7mG) (Figure 1.2) is well known in the role of capping mRNA
transcripts to stabilize and direct the processing of that RNA in eukaryotic translation26, 27.
However, the occurrence of the modification at position 46 of tRNA has a significant
influence on the viability of bacterial cells living at high temperature28. m7G is found in
both eukaryal and bacterial tRNA and is generated by methyl transferases trmB homodimer
(bacteria), Trm8/82 (yeast)29 and hMETTL1/hWDR4 (human)30.

The modification itself involves the transfer of a methyl group (SAM dependent) to
position 7 of the genetically encoded guanine. A deletion of the trmB gene in T.
thermophilis was shown to have a growth phenotype when incubated above 70°C. Analysis
of the produced tRNA showed that lack of the trmB gene product not only removed the
modification at position 46, but also produced hypomodification in m2G, m5U, m6A and
m1G. The melting point of the class I tRNA of this knockout was also found to be lowered
7

by 3.5°C when the cells were grown at 70°C and when grown at higher temperatures, the
change was reduced to -1.2°C (transcribed yeast tRNAphe had no significant change in Tm
by in vitro methylation). This decrease in thermal stability to is compounded by the
increased rate of in vivo degradation of specific tRNA (Phe and Ile). These effects result in
loss of translational fidelity and lead to the observed growth phenotype28.
Structural information is available regarding the interaction between 7mG46 and
surrounding bases. The crystal structure of tRNAPhe was solved with the modification in
place and it shows a non-canonical base pairing system with G2231. Hydrogen bonds form
between N1(46) and N7(22) and between N2(46) and O6(22) generating a trans
WC/Hoogsteen interaction. The bonding has been analysed using molecular modeling and
it has been calculated that the methylation confers a stabilizing effect of -15.12kJmol-1
compared to the unmodified basepair32.

Deazaguanine modified nucleobases

preQ0 biosynthesis
GTP is the first substrate in a series of reactions that create the queuosine and Archaeosine
33-35

intermediate, preQ0 (7-cyano-7-deazaguanine). The first enzyme, GTP cyclohydrolase

I (GCYH-I) acts upon GTP to form 7,8-dihydroneopterin-3’-triphosphate, releasing
formate36. This step is shared with the pterin and folate pathways. The product is then
converted to 6-carboxy-5,6,7,8-tetra-hydropterin (CPH4) by the enzyme QueD37. The next
step is a rearrangement performed by QueE generating 7-carboxy-7deazaguanine (CDG),
8

the first deaza- moiety in the pathway38. The final step is an amido transferase (QueC)
reaction, using ammonia as a nitrogen source to create the nitrile of preQ0 (Figure 1.3)37.
From this point the biosynthetic pathways diverge for the complete synthesis of Q and G+.

Queuosine pathway
In bacteria the free base preQ0 is transformed into 7-aminomethyl-7deazguanine (preQ1)
by the only known example of a nitrile reductase, QueF35. PreQ1 is integrated into substrate
tRNA by the enzyme tRNA-guanine transglycosylase (TGT). This enzyme concomitantly
removes the genetically encoded guanine base at position 34 (of those tRNAs with GUN
anticodon) and replaces it with preQ1. PreQ1 is the substrate for QueA, an Sadenosylmethionine:tRNA ribosyl transferase isomerase. In the penultimate step of this
pathway, the ribosyl moiety from SAM is not only transferred to the aminomethyl of preQ1,
but it is also isomerized to a carboxylate to give epoxyqueuosine (oQ-tRNA)39. The final
step in the pathway has been in part solved by the identification of an epoxyqueuosine
reductase (QueG) that utilizes cobalamine for the production of queuosine tRNA40 (Figure
1.4). Though queuosine is integrated into the tRNA of both bacteria and eukarya, de novo
synthesis of the modified nucleotide is only possible in bacterial systems41. In eukaryotic
systems the free queuine base can be integrated into tRNA by a eukaryotic specific TGT
enzyme42.

Archaeosine pathways
Unlike the queuosine pathway, the first step to occur in archaea after preQ0 synthesis is the
direct insertion into substrate tRNA. This occurs in tRNA that feature a genetically encoded
9

guanine at position 15. ArcTGT has been shown to perform a similar reaction to bacTGT
in which a transglycosylation reaction replaces the genetically encoded guanine with the
preQ0 base43, 44. The conversion of preQ0 to archaeosine was first shown to be performed
by the enzyme Archaeosine Synthase (ArcS). This enzyme (isolated from M. jannaschii)
has been shown to be an ATP independent amidinotransferase, utilizing glutamine,
asparagine or ammonia for direct transfer to the nitrile carbon of preQ045.

Though this discovery has completed the biosynthetic pathway in species which possess
the arcS gene, it is not the case that the enzyme is universally conserved. In those species
which do not produce ArcS, two alternative genes have been implicated in this final step46.
With particular bias toward the Crenarcheota, the genes queF-like and gat-queC have been
found to exist either in isolation or in some cases, in combination with arcS. E. coli cells
deleted of the queF-like gene, but transformed with a plasmid containing either queF-like
or gat-queC were found to produce tRNA modified with G+ (Figure 1.5). Furthermore, mass
spectrometric analysis of the RNA gave evidence for the modification taking place at
position 34, suggesting the activity of bacTGT was still functioning to replace that
genetically encoded guanine. The in vitro activity of QueF-Like has since been confirmed
to be the generation of archaeosine, acting on preQ0-tRNA as its substrate47. The enzyme
has also been tested on free preQ0 base which showed no activity. Finally, the enzyme is
more selective for the nitrogen source used compared to ArcS as only ammonia has been
shown to be active in this role and no G+ was generated when Gln or Asn were used.

10

Function of archaeosine

The modification of G15 to G+ has been shown to be a ubiquitous modification throughout
the Archaeal kingdoms except for the unusual species Haloquadratum walsbyi46. Since it
is absent from the other domains, it suggests that the role of G+ is either particular to the
Archaea, or its function has been supplanted by an alternative modification in the Bacteria
and Eukarya. The location of G+ at the very core of the tRNA structure, at the universally
conserved Levitt base pair, is also suggestive of a structurally significant role for this
modification.

Little information has been gleamed as to how this modification functions in vivo. The
nature of archaeosine’s role may be in forming enhanced contacts that stabilize a folded
RNA against more challenging environmental conditions. In silico studies, founded on the
structure of tRNAPhe, have shown that the presence of G+ will significantly change the
bonding engergies between two bases of the Levitt base pair (Figure 1.6) 48. The positive
charge developed at position 7 on the deazaguanine, is believed to subsume the effects of
coordinated metal ions (in the model described, a magnesium is bridged between the N7
and a solvent water oxygen).

This coordinated metal ion also serves as second mode by which the tRNA is stabilized.
Metal ions have been found to localize in the pocket between the N7 position and a series
of phosphate groups from U7, A14 and G15 itself (Figure 1.7). This dense pocket of
negative charge is neutralized by coulombic interactions with the metal ion (has been found
11

to be Mg2+ or Mn2+ in crystals structures). The formation of the positively charged center
of the formamidino ground of archaeosine, may be making a similar coulombic
contribution to the stabilization of the tRNA structure.

In this study we aim to investigate if archaeosine does in fact directly contribute to the
stability of tRNA. RNA structural stability is often analyzed by dissecting it in to individual
stems, stem loops and junctions that represent components of the overall folded RNA49-51.
These can then be used to build an ensemble image of both folded structure and dynamic
rearrangements that occur during the folding process.

UV absorbance hyperchromicity is one of the most direct methods of tracking the stability
of a given RNA. The absorbance of UV light as an RNA unfolds will increase as the molar
absorptivity increases. Using combinations of fluorescence, circular dichroism52 and
various other biophysical techniques53-57, the transitions seen in UV melts has been
correlated to specific elements of the tRNA falling apart. The first differential plot of
change in absorbance per temperature change reveals subpopulations of the structural
transitions that are often unclear in the direct melting profile (Figure 1.8). The generalized
folding pathway for tRNA established the importance of the interaction between the Dstem and T-stem in holding the native structure together58, 59. Loss of these structures and
intramolecular interactions trigger the complete loss of structure in biologically relevant
concentrations of Mg2+, leading to an effective two state model for the unfolding process.
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We plan to use this technique to exam the effect of G+ on the stability of in vitro transcribed
and modified tRNAs. This will provide a foundation to then study the effects of the
modification in the context of in vivo produced tRNA which has been maturated under
native cellular conditions and therefore contains all other modifications. Access to
knockout cell lines of the archaeaon Thermococcus kodakarensis, allows for the
progression of studying the genetically encoded guanine to preQ0 and G+ by extracting
tRNA from cells lacking arcTGT, ArcS or wildtype cells respectively.

NAD+ and NADP+ biosynthesis

The activity of nicotinamide adenine dinucleotide (NAD) was first shown in an extract of
yeast in the early 1900’s60. A dried extract which showed no independent fermentive
activity was able to enhance the rate at which a second yeast extract was able to ferment
glucose. This work would contribute to the awarding of the Nobel prize in 1929 to Harden
along with Von Euler for their work on coenzyme discovery and the fermentation of
carbohydrates. Indeed, von Euler was the first to identify the components of NAD, those
being the two ribose units, two phosphate units and one each of the adenine and
nicotinamide nucleobases. The involvement of nicotinic acid and its amide derivative in
NAD formation were implicated in a feeding study of dogs suffering from pellagra61.
Within the next twenty years, research had elucidated the complete biosynthetic pathway
to NAD and in a double publication both the intermediates involved in the synthesis and
the enzymes responsible for the chemistry were laid out62, 63.
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De novo synthesis of NAD (Figure 1.9) begins with the generation of nicotinic acid
mononucleotide (NaMN) which can proceed by two primary routes. Aspartic acid or
tryptophan can both be used as the starting reactant, undergoing 2-enzyme or 5-enzyme
steps respectively64. Both routes yield quinolinate as the immediate precursor which
undergoes a phosphoribosyl transfer step generating nicotinic acid mononucleotide
(NaMN)65. Adenylation of NaMN yields nicotinic acid dinucleotide (NaAD)66 and this is
the final intermediate before the action of NAD+ synthetase generates NAD+ using an
exogenous supply of nitrogen67.

As well as the de novo pathway there are multiple steps at which salvage pathways can be
implemented to replenish NAD+ levels. The Preiss-Handler pathway established that
nicotinic acid can be ribosylated directly to generate NaMN and then move through to
NAD+ as per the de novo route

62, 63

. Nicotinamide released by most of the non-redox

related processes of NAD+ metabolism is also ribosylated to yield nicotinamide
mononucleotide (NMN) and then adenylated to form NAD+66. Finally, nicotinamide
riboside (NR) has been shown to be regenerated to NAD+ by nicotinamide riboside kinase
generating nicotinamide mononucleotide which then undergoes an adenyltransferase step
to generate NAD+. This process can be performed by a single gene product in some systems
by the enzyme nadR 68.

Although globally the two routes to quinolinate are split between the domains (Asp typical
of prokaryotes and Trp largely found in eukaryotes), there is a high degree of interplay
within them. There are organisms from all three domains which apparently do not possess
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the genes needed for de novo synthesis. Likewise, there are bacteria that utilize
tryptophan64 and fungi that metabolize aspartate. Other examples have redundancies that
allow for switching between pathways depending on nutrient supply.

The activity of the related cofactor, NADP+, was discovered in the 1930s by Warburg and
Christian, when an erythrocyte extract and later hepatocyte extract were shown to be able
to reduce previously oxidized glutathione69, 70. The modification to NADP+ is a single
phosphorylation event at the 2’ position of the adenosyl moiety in NAD71. The NAD+
kinase is conserved through all domains of life and utilizes ATP to transfer the phosphate
group on to NAD+. This makes the biosynthesis of NADP+ explicitly coupled to the
biosynthesis of NAD+.

Roles of NAD+ and NADP+

The primary role of both NAD+ and NADP+ have long been known to be in redox reactions
where they act as electron carriers. Their structural similarities lead to them having near
identical redox potentials under physiological conditions and therefore, it could appear that
there is a redundancy in having these two species active in the cell. However, the need to
further modify NAD+ to NADP+ consumes ATP and so the energetic requirement alone
would suggest that there is a rationale for this redundancy. Upon inspection of the reactions
that the two cofactors are involved in, it becomes clear that they are partitioned between
anabolic processes (NADP+) and the oxidative processes for generating ATP (NAD+). The
phosphate group, held significantly away from the redox center, allows for the cofactors to
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have different binding modes. Within the cell, in order to help drive these two different
directions of reactivity, NAD(H) is held in an excess of the oxidized form and likewise,
NADP(H) is largely in the reduced (NAD+:NADH in humans has been measured to be as
high as 1820; NADP+:NADPH can be as low as 0.017) 72.

Due to the fundamental nature of the reactions that these cofactors are utilized by, they
have been studied extensively in their role as redox partners for vast numbers of reactions
in all domains of life (2200 of the reactions described on the KEGG database employ NAD+
or NADP+)73. It has also been determined that both NAD+ and NADP+ are involved in more
diverse reactions that take them beyond simple cofactors. It expands their role to cell
signaling and direct protein modification which brings in to play modulation of activity.

Both NAD+ and NADP+ can be processed to form secondary messengers. NAD+ is acted
on by ADP-ribosyl cyclase to generate cyclic-ADP ribose (cADPR), with the elimination
of nicotinamide. It has been shown that an increase in the cellular concentration of this
molecule (from endogenous synthesis and import) results in activation of the ryanodine
receptor channel on the endoplasmic reticulum and so increases cytosolic Ca2+
concentration. There is also activation of cell membrane channels to increase import of
Ca2+ ions. This is mirrored in the activity of the NADP+ metabolite (again with the release
of nicotinamide) nicotinic acid ADP, which causes a release of Ca2+ ions from lysozyme
related organelles, as well as the ER and activation of the same membrane channels as
cADPR. A third calcium mobilizing signal cascade is facilitated by NAD+ consuming
reactions. ADPR is able to upregulate calcium import by the TRMP2 channel. ADPR is
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synthesized by multiple routes but can be produced by the direct hydrolysis of NAD+ with
release of the nicotinamide moiety 74, 75.

A second route by which ADPR is generated is by the activity of the PARP enzymes that
are responsible for the maintenance of genome integrity in the nucleus. PARP or polyADPribose polymerase, use ADP-ribose to flag sites of single strand breaks in DNA. Proteins
in proximity to the break are modified by poly-ADP ribosylation, using NAD+ as the source
of the ADPR. Upon break down of this polymer, ADPR is released and this is translocated
in to the cytosol where its effects are described above 76.

Finally, one of the more recent roles of NAD+ is in the activity of sirtuins. NAD+ is utilized
by this universally conserved family of regulatory enzymes to deacetylate proteins that
have previously been modified to feature acetyl lysine. NAD+ is consumed, releasing
nicotinamide, along with O-acetyl-ADP ribose. Along with the deacetylase activity, some
members of the sirtuin families have also been shown to exhibit mono-ADP ribosylation
activity where the ADPR moiety is connected to the substrate protein via a bond to C177,
78

. However, the rates of these reactions is found to be several orders of magnitude lower

than the deacetylation reaction, and so it may be that the ribosyltransferase is merely a side
reaction. This notwithstanding, the activity of sirtuins implicates NAD+ in the regulation
of inflammatory response, apoptosis, glucose homeostasis, and the cellular stress
responses.
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Determination of NAD+ and NADP+ concentration

During the studies of these systems, there is an inherent need to obtain to determine the
concentration of the cofactors at a given point in a reaction being studied. Luckily, given
the nucleobase component of the molecules, there is significant absorbance within the UV
spectrum and the redox state of the cofactors results in a significantly different absorbance
spectrum. Both forms of NAD(P) show a strong absorbance peak centered at 260 nm.
However, the reduced form alone has a second significant peak centered at 340 nm. This
is true for both NADH and NADPH. The extinction coefficient for this 340 nm peak is
well characterized as being 6.22 x 103 cm-1M-1. This permits the trajectory of an NAD(P)
dependent reactions to be followed by either loss or appearance of this peak.79

Use of the absorbance is limited to instrumental sensitivity. This can be overcome thanks
to a phenomenon where by treatment of NAD(P)+ with strong base can generate a
degradation product which is fluorescent. This was initially observed in the analog
molecules diphosphopyridine nucleotide and methyl nicotinamide, where treatment with
5N KOH would yield a fluorogenic product with varied fluorescence yields80. This
treatment was found to be applicable to the NAD(P)+ systems and so a work up method
was established that allowed for robust quantitation of trace amount of NAD(P)+ in a
background of high NAD(P)H.

This section of work initially aims to reappraise the conditions used in this standard assay.
The conditions have remained unchanged since those proposed in the 1950s and though it
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is robust and consistent, it has not been investigated as to whether these can be improved
upon for working up NAD+ or NADP+. We also aim to finally confirm the identity of the
fluorescent species produced in the assay using these biological cofactors. The fluorophore
is usually measured in the background of other assay components, and so a purification
strategy will be employed to identify the fluorophore using standard spectroscopic and
spectrometric techniques for small molecules.
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Materials and Methods

Chemicals and Reagents

Buffers and salts of the highest grade available were purchased from Sigma unless
otherwise noted. DEPC (diethylpyrocarbonate) treated water was used for all solutions
used for RNA related assays81. All buffers and solutions were otherwise prepared with
Millipore MQ grade water. Dithiothreitol (DTT), isopropyl-β-D-thiogalacto-pyranoside
(IPTG), kanamycin sulfate, DEPC and ampicillin were purchased from RPI Corporation.
The radiochemicals [8-14C]-guanine and [U-14C]-L-glutamine were purchased from Perkin
Elmer. Adenosine, guanosine, ATP, GTP, UTP, CTP were all purchased from Sigma.
Nickel- nitrile tetraacetic acid (Ni2+-NTA) was purchased from Qiagen and Sigma.
Whatman GF-B filter disks were purchased from Fisher. Amicon centrifugal concentrators
were from Millipore. Dialysis tubing was obtained from Pierce. Plasmid Mini-Kits were
from Fermentas and Qiagen. Oligonucleotides were obtained from IDT. All reagents for
SDS-PAGE were purchased from BioRad. SDS-PAGE analysis was carried out using 12
% (29:1 Acryl:Bisacrylamide) gels and visualized with Coomassie Brilliant Blue. DNA
sequencing was carried out by the OHSU core facility in the Department of Molecular
Microbiology and Immunology. The substrate preQ0 was synthesized as described
previously and purified by reverse phase HPLC and stored at room temperature in
DMSO82. ß-Nicotinamide mononucleotide (NMN) was obtained from Sigma-Aldrich.
Both ß-nicotinamide adenine dinucleotide (NAD+) and the phosphorylated form (NADP+)
were obtained from RPI Corporation. Sodium hydroxide, hydrochloric acid, sulfuric acid,
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ammonium acetate and acetonitrile were purchased from Fisher. Quinine sulfate was
obtained from AnaSpec Inc. Deuterated solvents (water and sodium hydroxide) were
obtained from Sigma-Aldrich.

Instrumentation

Analytical HPLC was performed on an Agilent 1100 series HPLC (G1312A binary pump,
G1315A diode array detector). Preparative scale separation was achieved using a Hitachi
HPLC (L-6200 pump and L-4000 single wavelength detector). Rapid fluorescence
screening was performed using a Gemini XPS microplate reader from Molecular
Dynamics. Steady state fluorescence was carried out using a Quantamaster 400 from
Photon Technologies International. UV-Vis spectroscopy was carried out on a Varian Cary
100 Bio spectrophotometer fitted with a thermostatted multi-cell holder. Mass
spectrometry was performed on a ThermoElectron LTQ-Orbitrap Discovery high
resolution mass spectrometer with a dedicated Accela HPLC system utilizing ESI in the
Department of Chemistry at Portland State University. NMR studies were performed on
either 400 Hz or 600 Hz Brüker instruments belonging to the Department of Chemistry at
Portland State University. Infrared spectroscopy was carried out on a Nicolet iS10
spectrometer using a diamond ATR attachment.
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In vitro RNA preparation

Template preparation
Double stranded template DNA was prepared from two DNA primers which were designed
with a ten base pair overlap at the center of the target sequence83. The native gene sequence
was supplemented with the standard T7 promoter (5’TAATACGACTCACTATA3’) at the
5’ end of the upper oligo. The complete template is generated by primer extension using
the Klenow fragment (Fermentas) to create two fully complementary strands. The two
oligos are mixed to a final concentration of 4µM each, in the presence of dNTPs (600µM
each) and using the manufacturers reaction conditions. The primers are extended by cycling
25 times between 37°C and 10°C in 30 second pulses (Applied Biosystems 2720 thermal
cycler). The DNA was then extracted by phenol chloroform extraction (equal volume of
25Phenol:24Chloroform:1Isoamyl alcohol vortexed and then centrifuged at 13000 rpm for
5 minutes) and ethanol precipitation of the aqueous phase. The template was then
resuspended in water at 10µM.

Overexpression and purification of T7 RNA polymerase
The del172-73 mutant of T7 RNA polymerase was prepared by the overexpression of a
6His-tagged clone provided by Dr John Perona. Frozen cell stock (E. coli BL21(DE3)) was
grown on 200 µg/mL ampicilin agar plate and a fresh colony picked to start a liquid culture.
Cells were grown in LB with 200 µg/mL ampicilin and raised to an OD of ~0.9 at 37°C
with shaking at 220 rpm. Expression was carried out at RT with induction occurring upon
the addition of IPTG to a final concentration of 0.5 mM and growth occurring overnight.
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Cells were harvested by centrifugation at 5000 rpm (Sorval SLC-4000) and homogenously
mixed in buffer (100 mM Phosphate (pH 7.5), 100 mM NaCl, 1 mM β-ME, 200 µM
PMSF). To this was adeed Lysozyme (to 1mg/mL), and incubated for 20 minutes at 37°C
to breakdown cell wall before three rounds of -80°C freeze/thaw to lyse cell membranes.
Fully lysed cells are treated with DNaseI (20 µg/mL) and the lysate clarified by
centrifugation at 15000 rpm (Sorval SS-34) for 20 minutes at 4°C. Cell free extract was
loaded on to a Ni-NTA resin column, pre-equilibrated with 100 mM Phosphate (pH 7.5),
100 mM NaCl, 1 mM β-ME. Non-bound proteins were washed off with 10 column volumes
and then fractions were eluted with a stepwise gradient of 10, 20, 50 and 200 mM
imidazole. The target protein elutes with some contaminating proteins and so the 200 mM
fraction was dialysed (100 mM Phosphate (pH 7.5), 100 mM NaCl, 1 mM β-ME overnight
at 4°C using snake skin dialysis membrane) to remove the imidazole present and then run
through a Heparin column (GE Healthcare, HiTRAPP, 5 mL), the cleaned protein eluting
at 600 mM NaCl on a linear gradient. The protein was dialysed (overnight at 4°C) and
stored in 100 mM Phosphate, 100 mM NaCl, 1 mM β-ME, 25% glycerol and stored at 80°C.

Transcription reactions
RNA molecules were transcribed from 1µM DNA template in 30mM Tris-HCl (pH 8.0),
40mM MgCl2, 10mM DTT, 0.1% Triton X-100, 100µM spermidine, 2.5 mM NTP
(individual nucleotides obtained from Sigma, stock made up in DEPC water and stored at
-80°C), 50µg/mL of T7 RNA polymerase and 1U/mL of inorganic pyrophosphatase
(Sigma). The reactions are run for 4hrs at 37°C and quenched by ethanol precipitation. The
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recovered pellet was solubilized in DEPC water and then mixed with an equal volume of
formamide/5mM EDTA. The reaction products were denatured at 95°C and then separated
by denaturing urea PAGE (7M urea, 10% acrylaminde, 1x TBE, gel run at 18W). The full
length product band is excised from the gel and the RNA extracted by overnight crush and
soak in to 800mM ammonium acetate. The purified RNA was then precipitated and the
pellet resuspended in 1mM sodium citrate and stored at -80°C.

RNA modification enzyme expression and purification and use

ArcTGT expression
The tRNA-Glycosyl Transferase gene from M. jannaschii had been previously cloned in
to pET30, providing a 6-His fusion protein for expression in BL21 (DE3) E. coli cells. The
vector confers kanamycin resistance and so cells were grown in LB (pH 7.5) with
kanamycin at 50 µg/mL, to an OD of approximately 0.9 at 37°C. Expression of the fusion
protein is induced by addition of IPTG to a final concentration of 1 mM. Induction occurred
at 37°C for around 6 hours and resultant cells were harvested by centrifugation at 5000 rpm
(Sorval SLC-4000) for 15 minutes. These were resuspended in lysis buffer (50 mM TrisHCl at pH 8.0, 300mM NaCl, 1 mM β-ME, 200µM PMSF, 1 mg/mL lysozyme) and
incubated at 37°C for 20 minutes before being put through three cycles of freeze thaw to
lyse. DNase I (20 µg/mL) treatment followed by centrifugation (15000 rpm for 15 minutes
in a Sorval SS-34 rotor) generates a cleared lysate that can be passed over a Ni-NTA
column for affinity chromatography of the target enzyme. The protein elutes at 50 mM
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imidazole from a stepwise gradient (0, 10, 50 and 200mM). The appropriate fraction is
collected, concentrated and dialysed in to storage buffer.

ArcS expression
Archaeosine synthase from M. jannaschii had previously been cloned in to a range of
plasmids, but for all expression in this work the clone is in pET32-Xa. This provides a
thioredoxin domain at the N-terminus to assist in the folding process. Expression of the
protein requires it be transformed into Rosetta (DE3) E. coli. These cells were grown in
LB supplemented with kanamycin (50 µg/mL), sorbitol (0.5 M) and betaine (5 mM) at
37°C. At an OD of approximately 0.9 the cells were induced to express with IPTG at a
final concentration of 0.25 mM. Induction was carried out at room temperature for 8 hours.
The cells were harvested by centrifugation at 5000 rpm (Sorval SLC-4000). Cells are
resuspended in lysis buffer (100 mM HEPES pH 7.0, 500 mM NaCl, 1 mM β-ME and 200
µM PMSF). Cells are then incubated with lysozyme (1 mg/mL) and freeze thaw cycles
used to lyse cells. Lysate was cleared by centrifugation at 15000rpm (Sorval SS-34 rotor)
for 15 minutes. The enzyme was obtained by passing the protein suspension over a NiNTA column isolating the 6His-TRX-ArcS fusion. Elution occurs at 50 mM imidazole and
the fraction was collected before being concentrated, dialysed into imidazole free buffer.
Factor Xa was added so that 1 µg was present for every milligram of fusion protein. The
tag is removed by running back over a column of nickel resin to which the cleaved protein
no longer binds. The protein is concentrated and dialysed in to storage buffer (100mM
HEPES pH 7.0, 500 mM NaCl, 1mM β-ME, 25% glycerol) and kept at -80°C.

25

Preparation of preQ0 tRNAs
All appropriate tRNAs were modified to feature preQ0 base by the action of arcTGT.
Standard reaction conditions were 50 mM succinate (pH 5.5), 20 mM MgCl2, 100 mM
KCl, 2 mM DTT, 100 µM tRNA and 1 mM preQ045. RNA was heated at 80°C for 3 minutes
before adding in ArcTGT to a final concentration of 10µM and incubating for a period long
enough to ensure complete incorporation. Activity of the enzyme was assayed by reacting
the RNA with the enzyme in the presence of
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C-Guanine in place of the preQ0 native

substrate. Incorporation of radionuclide was determined by scintillation counting of
ethanol precipitated RNA trapped on glass fiber filter papers. The reaction was terminated
by the addition of 1/10th volume of 8M ammonium acetate. Reaction components were
removed by phenol/chloroform extraction, and the aqueous phase precipitated by the
addition of two volumes of ethanol. The reaction was repeated for two more rounds of
incorporation to ensure complete integration of preQ0 base.

Preparation of G+ tRNAs
The modification to Archaeosine tRNA was produced by the enzyme ArcS. Previously
modified preQ0-tRNA is suspended (50µM) in 100 mM HEPES (pH 7.0), 0.5 M NaCl, 20
mM MgCl2, 5 mM Glutamine, 1 mM DTT with 10µM ArcS. The sample was reacted for
1 hour at 40°C. The modified RNA was isolated by ethanol precipitation using 800mM
NH4OAc, quenching reaction and removing the other reaction components
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Thermococcus kodakarensis culture

Media preparation
Stock solutions (500x) were prepared for both vitamins and trace elements.

The

components and end concentrations of these are; vitamin mix (8 µM biotin, 5 µM folic
acid, 50 µM pyridoxine, 15 µM thiamine, 15 µM riboflavin, 40 µM nicotinic acid, 20 µM
Ca-pantothenate, 7 µM p-aminobenzoic acid and 75 nM B12) and trace minerals (50 µM
FeCl3, 5 µM MnCl2, 18.5 µM CoCl2, 7 µM CaCl2, 7.5 µM ZnCl2, 1.5 µM CuCl2, 1.6 µM
H3BO3, 1 µM (NH4)2MoO4, 5 µM NiCl2, 850 nM NaSeO4, 2 µM AlCl3).

Additional components per liter of growth medium:
Yeast extract (2.5g), tryptone (2.5g), NaCl (10.2g), MgCl2.6H2O (2.4g), MgSO4 (0.8g),
CaCl2.2H2O (0.4g), KCl (0.3g), sodium pyruvate (2.5g), agmatine sulfate (0.6g).

Media is prepared under N2 to remove all dissolved O2 (resazurin added to 1 mg/L) and
autoclaved to sterilize. Before inoculation the head gas was exchanged for 80:20 N2/CO2
to 10 psi. To ensure fully anaerobic conditions, the growth media was spiked with further
Na2S (from a 2.5% w/v stock) until resazurin remained colourless.

Cell growth
Starter cultures were grown at 60°C overnight in 10mL cultures in Huntgate tubes with a l
mL inoculation from stock culture. The cells were then grown in 1 litre culture volumes.
The media and starter culture were brought to target growth temperature before the entire
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starter culture was transferred to the larger flask and cells allowed to grow for at least 16
hours.

Confirmation of knockdown by PCR of genomic material
Harvested cells were resuspended in 50mM Tris.HCl at pH 8.0. The cells are melted by
pheno/chloroform extraction. The genomic material is isolated by collecting the extraction
aqueous supernatant and adding 1/10th volume of 8M ammonium acetate and 2 volumes of
cold ethanol. The genomic DNA is removed by sterilized glass rod and transferred in to
50mM TE. Primers used for amplification of the genes (Table) were provided by the
Santangelo group and were designed to anneal upstream and downstream of the gene itself,
producing bands larger than the gene if it is intact, and greatly reduced in size if it has been
removed. PCR was performed using Phusion DNA polymerase (Thermo) with standard
manufacturers reaction conditions and performing 25 rounds of amplification at 55°C
annealing temperature (15 seconds) and extension at 72°C (90 seconds). Reactions were
separated on a 0.6% agarose gel in TEAE buffer with ethidium bromide for visualization
by transillumination.

In vivo tRNA extraction
Incubation of whole T. kodakarensis cells from culture with phenol:choloroform:IAA
(25:24:1) is sufficient to release cell contents. In order to help separate protein, lipid and
DNA from the bulk RNA species, the cells are first suspended in 100mM ammonium
acetate (pH6.5) with 10mM MgSO4 and 0.1 mM EDTA. Upon addition of saturated phenol
mix RNA remains in the aqueous phase and most other components move to the organic
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phase following centrifugation. The bulk RNA is precipitated by adding 1/10th the volume
of 8M ammonium acetate and two volumes of ethanol and cooling to -20°C for two hours.
The precipitated RNA is pelleted by centrifugation at 15000 rpm (Sorval SS-34 rotor) for
25 minutes at 4 °C. The pellet is resuspended in 100mM ammonium acetate (pH6.5) with
10mM MgSO4 and 0.1 mM EDTA, an equal volume of 8M LiCl was added and the mix
cooled at 4 °C overnight. Precipitated rRNA species were removed by centrifugation,
followed by tRNA precipitation with the addition of ammonium acetate/ethanol as above.

Isolation of tRNA for mass spectrometric anaylsis
Total RNA was extracted as above, however to prepare total tRNA for MS analysis solid
phase extraction was employed to reduce the counter ion species present. Nucleobond
RNA/DNA 400 columns (Macherey-Nagel) were employed to separate high mass RNA
molecules and total tRNA. Pelleted total tRNA was suspended in the appropriate buffer
according to the manufacturers guidelines. The fractionation is based on a step gradient of
salt concentration with tRNA eluting in 0.65M KCl and higher mass molecules eluting in
1.15M KCl. The RNA population in sub-fractions were confirmed by urea PAGE. The
isolated tRNA is precipitated in 800mM ammonium acetate/ethanol. This is repeated three
times to substitute the K+ for ammonium ions. The sample was then dried and sent to the
Limbach lab for analysis (University of Cincinnati).

Isolation of isoacceptor tRNA
The Gln isoacceptors for T. kodakarensis were isolated by affinity purification from the
total tRNA pool. Streptavidin agarose (Thermo Scientific) was loaded with a biotinylated
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DNA oligo that complements a particular stretch of the target tRNA sequence. The resin
was activated by binding the biotinylated oligo to the streptavidin (oligo at 15µM in 10mM
Tris-HCl (7.5), 100mM NaCl). For annealing of the tRNA to the immobilized DNA, the
total tRNA is dissolved in annealing buffer (10mM Tris-HCl (7.5), 900mM NaCl, 1mM
EDTA) and heated to 95°C for 5 minutes. After cooling to 85°C the resin (pre-equilibrated
in annealing buffer) is added and the slurry is allowed to fully cool to room temperature
with occasional mixing. The unbound RNA is removed by centrifugation and washing with
elution buffer (10mmM Tris-HCl (7.5), 100mM NaCl) until OD260 was below 0.01/mL.
Elution was achieved by re-suspending the resin in 0.5 ml of elution buffer and heating to
75°C for 5 minutes before centrifuging to collect the Glx tRNA.

Biophysical analyses

UV melting studies
All thermal denaturation studies were performed on the Cary 100 Bio UV-Vis
spectrophotometer. Single wavelength absorbance was used to record the unfolding of the
tRNA species being studied. Temperature was adjusted by a thermostatted cell block holder
under peltier control. The thermal melt cycle was controlled by the Thermal program in the
Cary Win UV software suite. Samples were prepared in 10mM sodium cacodylate at pH
7.0 with a background of 100mM NaCl. This was supplemented with either EDTA or
MgCl2 where indicated. RNA was slow cooled from 98°C to 55°C, at which point the
sample was spiked with the additives mentioned previously and allowed to cool down to
room temperature. During analysis, sample volume (120µL) is covered with mineral oil to
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prevent evaporation. The sample is monitored at 260nm during the melt and the Tm
determined by performing the first derivative of the absorbance value.

Magnesium binding
In these experiments competition is set up between the binding affinity of the folded RNA
for Mg2+ ions and that of the fluorescent molecule HydroxyQuinoline-5-Sulphonic acid
(HQS). The dye was prepared by recrystalisation from boiling conc. hydrochloric acid
(repeated six times). All solutions were prepared from Chelex treated deionized water to
minimize metal ion contamination and stock buffers were kept with aliquots of resin to
maintain this. The dye was quantified and diluted to 25 µM in 10mM Sodium cacodylate
pH 7.0, 100mM NaCl, 10µM EDTA and kept at 37 °C. Magnesium chloride stocks were
prepared from high grade salt and the concentration of an approximate 2M stock was
accurately determined by back titration with EDTA. The dye solution was transferred to a
quartz fluorescence cell and the signal at 550 nm (excitation at 395 nm) recorded upon
addition of magnesium chloride in minimal volume steps. The titration was then repeated
in the presence of 25 µM natively folded tRNA (purification of RNA in TE buffer
effectively removes divalents and refolding was performed with sodium chloride as
described previously)

HPLC analysis
All HPLC steps were performed on Agilent 100 system fitted with a multiwavelength diode
array detector. Analytical work was performed on Gemini columns, either small scale (5
µm C18, 30 x 4.6 mm; 1.0 mLmin-1), or full analytic resolution (5 µm C18, 250 x 4.6 mm;
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0.3 mLmin-1) both from Phenomenex. Large scale purification used a Luna column (5 µm
C18, 250 x 10 mm; 3.0 mLmin-1) from Phenomenex. All solutions were prepared in MQ
water and using HPLC grade salts and solvents.

Preparation of nucleoside digest of tRNA samples begins by dissolving the sample in
water. 100µg of RNA are adjusted for the first step by addition of 1/10th volume of 100mM
sodium acetate at pH 5.5. Nuclease P1 (Penicillium citrinum from Sigma) is added at 0.5µg
per 100µg of RNA. This is allowed to digest at 50°C for 4 hours. The pH is adjusted by
direct addition of 1/10th volume of 1M ammonium bicarbonate. Snake venom
phosphodiesterase is then added to the reaction mix (0.01U) and allowed to react for 1 hr
at 37°C before adding 2U of bacterial alkaline phosphatase for a further 1hr at 37°C. This
mixture can be directly analysed by RP-HPLC.

Product synthesis and purification

Each of the three possible substrates NMN, NAD+ and NADP+ were handled in the same
way in order to generate the target fluorophore species. The required mass of material was
dissolved in MQ water to a concentration not greater than 300 mM. To this was added an
equal volume of 4 M NaOH leaving the reactant at 150 mM and the base concentration at
2 M. This mixture was allowed to react for 2 hrs in the dark. At this time the reaction was
quenched by the addition of conc. HCl until pH was neutral. The reaction mixture was then
initially analysed by reverse phase HPLC using a Gemini column (5 µm C18, 30 x 4.6 mm;
1.0 mLmin-1) from Phenomenex and a linear gradient from 100% 100mM NH4OAc (pH
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6.8) to a final concentration of 30% acetonile in the same aqueous solution. This utilized
the Agilent instrument and recorded spectra from 220-400 nm throughout the elution.
Purification was scaled up and utilized an isocratic elution of either 100mM NH4OAc (pH
6.8) or just MQ water. Large scale purification employed a Luna column (5 µm C18, 250
x 10 mm; 3.0 mLmin-1) from Phenomenex, and elution tracked by monitoring the
absorbance at 360 nm. The initial fraction containing the fluorophore was reinjected
through the same column and mobile phase conditions for further purification. This fraction
was recovered in 1 mL fractions and the fluorophore content determined by adding 10 µL
in to 200 µL of 2 M NaOH and collecting fluorescence spectra (ex 360 nm and em 400500 nm). The purity of the fraction was also determined by injecting a 10 µL aliquot of the
fraction on to the Gemini column described above.

Spectral properties

UV absorbance and fluorescence spectra and pH dependence
Absorbance spectra for the isolated fluorophore were measured on the Cary 100. HPLC
fractions, containing the highest purity of the fluorophore, were diluted in to either
Millipore water or 0.5 M NaOH in order to determine solvent effects on the chromophore.
The spectra were collected using 2nm slits on the excitation path and scanning between
220 and 400nm. In measuring emission spectra, the samples were analysed on the PTI
Quantamaster measuring emission between 390 and 600 nm with excitation centered at
360 nm and 2 nm slits (5 nm slit on the emission path)
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Quantum yield determination
The fluorescence quantum yield for the product was measured in 0.5M NaOH and carried
out at concentrations that gave an absorbance between 0.01 and 0.1 OD to minimize any
internal quenching effect. At each concentration the absorbance was measured at 25 °C on
the Cary 100 UV-Vis spectrometer (200-400 nm scans with excitation slit set to 2 nm and
0.5 second averaging time). The samples were held in a 9F-Q-10-GL14 cuvette (Starna
Cells) and 1mL of sample was measured to minimize noise. A second aliquot of the sample
at each concentration step was then measured in the steady state fluorimeter (PTI
Quantamaster 400) using the same cuvette. The fluorescence spectra were recorded at 25
°C (thermostatted with a circulating water bath) from 400 to 600 nm (5 nm slits on
emission) with excitation at 360 nm (2 nm slits on excitation). Each absorbance and
emission spectrum was collected in triplicate and averaged before being plotted to
determine the linear response. This process was repeated using the standard quinine sulfate
in 0.5 M H2SO4. Concentrations in the same absorbance range were prepared and the
absorbance and emission spectra were collected with exactly the same instrumental set ups.
The two linear responses were then used to calculate the quantum yield of the base product
using the standard value for quinine of 0.54 and the following relationship:

Φx = Φquinine

Gradient x
Gradientquinine
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η2 x
η2 quinine

Product identification

NMR spectroscopy
After bulk purification as detailed above (mobile phase was Millipore water), the sample
was concentrated in order to perform NMR studies. This was achieved by drying under a
low flow of nitrogen gas at room temperature in the dark. To the concentrated aqueous
sample was added 10% D2O to allow for locking signal. Water suppression experiments
on the neutral solution along with sample supplemented with sodium deuteroxide to
100mM were collected on the 400Hz Bruker instrument. This system was also used to
collect C13 and H1/C13 HSQC spectra. Finally, N15 and H1/N15 HSQC experiments were
run on the 600Hz instrument. Standard pulse sequences provided by the core facility were
used in each case.

Mass spectrometry
In order to obtain an accurate mass for the fluorophore being studied the sample was freshly
prepared and passed through the Gemini (30 x 4.6 mm) column. The eluted fluorophore
was at this point in water and so to increase volatility for ESI methodology it was mixed
50:50 with methanol. The prepared sample was immediately injected on to the mass
spectrometer by direct infusion and the mass profile recorded in positive mode. The ESI
interface was operated in the positive mode using the following settings: spray voltage 3.8
kV; capillary temp 300 °C; capillary voltage 13.89; tube lens voltage 120V.
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IR spectroscopy
FT-IR spectra were collected on a Nicolet iS10 spectrometer using a diamond ATR
attachment. The sample was extracted from aqueous solution using ethyl acetate which was
then dried to concentrate. The sample was drop cast on to the crystal and the ethyl acetate
dried before analyzing the unknown against the appropriate background zero.
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Results

Role of archaeosine in tRNA

Thermal stability of in vitro modified tRNA
The initial work for this section of research began by studying the effects of magnesium
on the stability of a set of tRNA molecules that have been modified in vitro to feature either
the genetically encoded guanine, preQ0 or G+ nucleobases at position 15. For this reason,
SerCGA from Haloferax volcanii was initially selected as it had been used to study the
activity of the two biosynthetic enzymes in the pathway45. A second archaeal tRNA was
selected that features a reduced variable loop compared to the type II Serine sequence.
Methanothermobacter thermautotrophicus GlnUUG was chosen here for it having been
studied extensively in its folding pathways

84, 85

. Finally, the GlnUUG sequence from

Escherichia coli was chosen as a non-archaeal system that could be modified to feature the
archaeal modifications.

Preparation of in vitro modified tRNA
The RNA molecules were prepared from duplex DNA template synthesized by primer
extension using Klenow fragment83. The native sequences for all three RNAs were used,
no modification to enhance transcription yield was introduced (Table 1). The Klenow
templates were transcribed using in house expressed and purified T7 RNA polymerase.
The reaction mixtures were stopped and precipitated before being purified by slab
denaturing PAGE. The isolated full length RNA products were then modified in vitro to
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have the genetically encoded G converted to preQ0 by the action of ArcTGT (Figure 3.1).
The purified enzyme was assayed for activity by measuring the incorporation of [8-14C]
guanine into a small preparation of the tRNA, establishing the conditions for quantitaive
incorporation of substrate base. These conditions were then scaled and substituted with
preQ0 base to substitute the guanine (Figure 3.3). A portion of the preQ0 modified tRNA
was set aside for melting studies and the remainder serving as a substrate for the next
reaction using ArcS (Figure 3.2) to produce G+ modified tRNA. Quantitation of conversion
to G+ was determined by digesting the tRNA to free nucleoside and confirming the loss of
preQ0 and appearance of the G+ in the chromatogram (Figure 3.3).

UV melting study of in vitro tRNA
The nine RNA samples described above, were then carried on to perform melting studies
of the tRNA under the effects of increasing magnesium concentration. Each sample was
slow cooled in melting buffer (10mM sodium cacodylate pH7.0, 100mM NaCl) from 98
down to 25°C. If magnesium was to be added, the RNA was heated back up to 55°C before
the required amount magnesium chloride stock solution was added and re-cooled to 25°C.

The raw melt data was first processed to obtain a melting profile (first differential plot of
dAbs260nm vs [Mg2+]) to allow the apparent Tm to be deduced. The extracted Tm value was
then plotted against magnesium concentration to reveal the magnesium induced
stabilization of the tRNA structure. The isotherm was fitted using a two state model giving
a calculated lower and upper limit for the magnesium response (Figure 3.4). It also extracts
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a half magnesium concentration for each RNA species relating to sensitivity of the response
to magnesium concentration.

As summarized in Figure 3.5 it can be seen that by increasing the concentration of
magnesium ions (up to a maximum of 50mM) to which a given RNA is exposed produces
an increase in melting temperature of around 20 degrees. By comparing the magnesium
free Tm values across the samples we see that two GlnUUG isoacceptors have the higher
initial melting point compared to the HV SerCGA. Both HVser and ECgln show very little
change in the calculated maxima and minima with the addition of either preQ0 or G+. The
only significant change is seen in the MTgln RNA where the magnesium free Tm increases
from 68.3°C to 70.5°C and finally 71.2°C as the modifications are introduced. This is
mirrored by the high magnesium concentrations producing nearly a two-degree increase in
Tm when the RNA is modified to G+ from preQ0. The lack of any real change in the [Mg]1/2
value indicates that there is not a sudden increase in the sensitivity of the RNA to
magnesium upon introduction of the modifications. If the midpoint had shifted to a
significantly lower magnesium concentration it might be argued that there was a particular
stabilizing effect relating to magnesium binding that was being titrated.

Magnesium binding to modified tRNA
Since the formamidino group introduced at N7 in Archaeosine is implicated in changing
the electronics of the base and also the coulombic interaction with surround phosphates,
normally facilitated by a coordinated divalent ion, we next investigated the effect of
modification on magnesium binding. Methodology used extensively by the Draper group
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had shown that the fluorescent dye molecule 8-hydroxyquiniline-5-sulfonic acid (HQS)
can be used to set up an equilibrium competition experiments that can sense magnesium
affinities in RNAs. The binding of magnesium ions is partitioned between the HQS and a
target RNA. To examine the change in magnesium binding caused by modification to
preQ0 and G+, the modified in vitro RNA was used in the assay.

The baseline response to magnesium needs to be established to achieve a differential in the
presence of the subject tRNA. The dye was prepared by recrystalisation from boiling conc.
hydrochloric acid (repeated six times). This ensures that the dye was completely
demetallated before use (spectral properties confirmed before use) (Figure 3.6). The dye
solution was transferred to a quartz fluorescence cell and the signal at 550 nm (excitation
at 395 nm) recorded upon addition of magnesium chloride in minimal volume steps. The
titration was then repeated in the presence of 25 µM natively folded tRNA (purification of
RNA in TBE buffer effectively removed divalent metal ions and refolding was performed
with sodium chloride as described previously). The increase in the fluorescence in response
to magnesium was now delayed, reflecting a preferential binding to the RNA. The position
of this equilibrium can be deduced by comparing the two titrations. As the Kd of
magnesium binding to the RNA becomes tighter, the apparent Kd for HQS becomes weaker
since more magnesium ions need to be added before they become free to associate with the
dye. Analysis was performed on normalized data, using a reduced Hill equation to fit the
raw data. This provides a minima and maxima for each RNA titration with which the
normalization was performed.
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Titrating HQS against magnesium gave a [Mg2+]1/2 of 343 µM in the absence of competitor
RNA (Figure 3.6). Addition of unmodified tRNAGln from M. thermoautotrophicum shifted
the observed affinity to approximately 1.65 mM clearly showing that the experiment was
reporting the phenomenon appropriately. The preQ0-tRNA shows a very similar response
to unmodified tRNA with a [Mg2+]1/2 of 1.62 mM. G+-tRNA however, gives an apparent
[Mg2+]1/2 of 961 µM. This means that at a given concentration of magnesium, unmodified
and preQ0 have a stronger affinity for magnesium than G+ modified tRNA. By applying the
following equation 86:

it is possible to deduce a preferential binding constant (G2+) for an RNA at a given
magnesium concentration and therefore the change in magnesium ions per nucleotide or
RNA molecule. Although there is a change in the amount of magnesium binding to the G+
RNA, it appears to be more in line with diffusely interacting ionic contacts rather than the
loss of a singular coordinated ion. The preferential binding coefficient increase with
magnesium concentration, and at 1mM we see approximately 20 fewer ions binding per
tRNA molecule in the G+ modified tRNA compared to the unmodified transcript.

In vivo modified tRNA from Thermococcus kodakarensis
Although it is possible to analyze the effects of singular modifications upon the stability of
a given tRNA, in vivo samples would allow us to measure the effects of a given
modification in an otherwise fully maturated molecule. In order to access tRNA which is
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either un-modified, preQo modified or modified with G+ it is necessary to obtain genetically
modified cell lines that have had arcTGT or ArcS deleted from the genome of an archaeal
species. There are limited numbers of archaeal systems that have sufficient genetics tools
available to produce selective knockout cell lines. One of these is fortunately the
hyperthermophile Thermococcus kodakarensis. The work of Tom Santangelo’s lab is
systematically cataloguing knockouts of all the genes in that species genome. The group
kindly provided cell lines for TS559 (wild type), TK0760 (Dtgt) and TK1256 (DArcS).
These are stable deletions where the gene of interest is not only removed from the genome
but also the recombination vector is lost from the cell. The mechanism for creating the
knockout is illustrated in (Fig 3.7)87.

Growth of the cell lines
The TS559 cell line is auxotrophic for agmatine by removal of the pyruvoyl-dependent
arginine decarboxylase (TK0149). This means that although the tgt and arcS genes are
stably deleted, in order to grow the cell lines, they must be supplemented with agmatine.
Rich media was used to make as much biomass as possible. Under these conditions, cells
were either grown overnight (16hrs) at 85°C or 20 hours at 60°C before harvesting by
centrifugation. Up to 0.9 grams of cells can be harvested per liter of growth media. Before
going forward with tRNA isolation, the deletions were confirmed by PCR amplification of
each gene for the three cell lines. The genes of interest are appropriately removed (Figure
3.8).
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Isolation of tRNA from the knockout cell lines.
In order to access the pool of tRNA produced by the TKO cells, they are immediately
suspended in Trizol solution after harvesting. The non-RNA components are stripped away
by multiple round of PCA extraction leaving behind a total RNA pool. The RNA is cleaned
of non-tRNA species by LiCl precipitation (Figure 3.9). Analysis of the nucleoside digest
of the in vivo tRNA shows that the cell lines have the predicted pattern of modified bases.
PreQ0 and G+ nucleoside are absent from the Dtgt strain. PreQ0 is present in the DArcS
strain and only the wildtype show G+ detectable by absorbance in the HPLC chromatogram.

For mass spectrometry analysis (performed by the Limbach lab) tRNA was isolated by SPE
column. This permits isolation of tRNA enriched samples without introducing any PAGE
artifacts to the sample. Analysis of the three cell lines shows that though no G+ is seen in
either the TGT or ArcS knockouts by RP-HPLC, there is approximately 1.6% intensity of
the wild type observed for the DArcS sample by MS (Figure 3.10).

Purification of the GlnX isoacceptor
Since both isoacceptors for the Gln encoding tRNA are identical except for the anticodon,
it was not possible to isolate just that of CUG. However, the environment of G15 in both
sequences should be identical, and the sequence of the ACL should be of no consequence
to the overall stability of the tRNA. In comparing the sequences of all the TKO tRNA
genes, it was found that the area most unique for Gln was from the ACL leading to the 3’
end of the molecule. DNA oligos were designed to walk along the length of the tRNA in 3
43

nt steps (Figure 3.11). By slow cooling the transcribed tRNACUG with the DNA oligos it
was possible to identify the best candidate for forming a stable and appropriate complex.
The oligo Aff3 was found to sequester most of the RNA in to a particle that moved through
the gel rather than making a large multiple strand complex as seen in Aff1 and Aff2 (Figure
3.12). The selected sequence was prepared as a 5’ biotinylated strand that was able to be
loaded on to streptavidin sepharose to make an affinity resin for the GlnX tRNAs88.
Isoacceptor was extracted from all three cell lines by elution of the RNA by heating the
resin to 75°C in low salt buffer. The wash fractions and elution are shown in (Figure 3.12).
The isolated tRNA was should to be homogenous in both denturing (Urea TBE PAGE) and
native (TB, 100mM NaCl PAGE) (figure 3.13)

Thermal stability of single isoacceptor tRNA
To be able to directly compare the melt behavior of the tRNA extracted from the T.
kodakarensis strains, the thermal stability of in vitro produced tRNACUG (TKO sequence)
was tested under increasing Mg2+ concentrations (Figure 3.14). The melts of the wt, preQ0
and G+ modified tRNA are shown alongside the sequence details. The unmodified in vitro
tRNA shows a shoulder in the differential plot at around 70°C along with the major melting
transition at 85°C under 100mM NaCl. This has shown that the tRNA is inherently more
stable than the three other tRNAs studied previously. Under the same salt conditions, the
preQ0 and G+ modified tRNAs also feature a slight shoulder nearer 65°C, but the major
melting transition occurs a few degrees above that of the unmodified CUG. As the
concentration of magnesium ions is increased up to 10mM, it is seen that the shoulder
persists, though the peak does increases to around 71°C for all three RNAs. At the highest
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magnesium concentration, the melting transition is not completed by 98°C which is the
highest temperature reached in the melt. This indicates that the tRNA is melting fully at
least 10-12°C above the HV and MT tRNA with the same modifications in place.

When the in vivo produced and modified tRNA (Figure 3.15) is put through the same
melting experiment, we see a significantly different trend. The WT (containing G+) and
dTGT (the genetically encoded guanine base) behave almost identically. There is still a
slight shoulder at around 71°C and a second melting point at around 83°C. This higher
melting temperature is similar for the dArcS (containing preQ0) but there is a more
pronounced shoulder at around 63°C with this RNA. The addition of 10µM Mg2+
introduced to the system has no measurable effect on the melting transitions. At 100µM
Mg2+ however, the WT and Dtgt profile has collapsed in to a single and well defined
transition at about 82°C. At the same concentration, the tRNA from DArcS has the major
transition occurring at 73°C with a shoulder at 86°C. At 1mM Mg all three RNAs are
melting with a single transition, though DArcS is 4°C lower than the WT and Dtgt. This is
maintained at 10mM Mg where all three RNAs are melting at a temperature beyond the
98°C limit of the experiment.
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Identification and characterization of NAD(P)+ base product

Stability and assay conditions
The assay studied here begins with an initial acid quench step where by the total reaction
mix is adjusted to be in 150mM HCl. This will not only stop the reaction by denaturing the
protein component, but it also decomposes any unreacted reduced NAD(P)H so that no
further production of NADP+ can occur after the end point has been defined (Figure 3.16).

The conversion of NAD(P)+ to the fluorescent product is achieved by adding concentrated
base, typically to a final concentration of 7M NaOH. This is incubated at room temperature
for 2 hours to develop the fluorescent molecule, however it is unclear from the literature if
their conditions are optimal for maximal production of fluorescent product and thus assay
sensitivity. To determine the conditions for optimum yield, a 50mM solution of NADP+
was treated with NaOH over a concentration range from 1-10M. Immediately after being
added to the sodium hydroxide solutions an increase in fluorescence is observed that
correlates to with the concentration of NaOH (Figure 3.17). This trend does not persist
upon longer incubation. Left at room temperature overnight and in the dark, the
fluorescence yield is maximal at between 2 and 3 M NaOH and produces a 35% increase
over the same treatment at 7M NaOH (Figure 3.17).

The 2M base conditions were then used to track the progress of the reaction at lower base
concentration. The same 2-hour incubation time prescribed by the original assay was
analysed by RP-HPLC. It is shown that intact NADP+ is entirely consumed by 20 minutes
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of exposure to 2M NaOH. The remaining time causes two unidentified products to
exchange, both eluting long before NADP+ or the fluorescent product.

Equivalency of substrates
In order to ascertain if the adenosine group is involved in the formation of the fluorophore,
NADPH and nicotinamide mononucleotide (NMN), the latter of which lacks the adenosine
moiety, were treated with the 2M NaOH work up conditions. NADPH, NADP+ and NMN
were all prepared as 50 mM aqueous solutions. The absorbance spectra of both NADP+
and NMN are dominated by a peak at ~260nm (Figure 3.18). The spectrum of the reduced
form, NADPH is further characterized by a peak at 340nm. Upon treatment with sodium
hydroxide (equal volume of 4M NaOH added to the 50mM stock for 2 hours at room
temperature, neutralized by addition of HCl) the absorbance spectrum of NADPH remain
relatively unchanged either when diluted in to MQ water or back in to basic conditions (1M
NaOH). The peak at 340nm persists in water but there is a slight red shift when measured
in base. In contrast, NADP+ and NMN show a drastic change to their spectra. In the case
of NADP+ a new band appears at approximately 340nm when measured at natural pH, and
shifts to ~360nm under alkaline conditions. This corresponds to the absorption band
utilized in the assay. The spectrum still features a large peak at 260nm which corresponds
to the adenine moiety. In the reaction involving NMN which is the peaks observed in both
water and 1M NaOH match those observed for NADP+, but the spectrum at lower
wavelengths is no longer swamped by the 260nm peak, revealing base- sensitive fine
structure below 260nm. This confirms that the fluorophore produced by base treatment of
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NAD+ or NADP+ is generated independently of any involvement of the bridging
phosphates or adenosyl moiety.

Spectral properties

Absorbance and fluorescence spectra
To characterize the fluorescent product a purification strategy needed to be developed in
order to isolate it from the rest of the reaction side products. Analytical scale purification
by reversed phase HPLC using 100mM ammonium acetate (pH 7.0) showed good
separation with just an isocratic run on a C18 column. In order to obtain the fluorescent
product free of other species the preparative scale separation was performed from the
neutralized reaction mix, using a mobile phase of just MQ water. The isolated product was
then kept in solution and adjusted to be at a useful concentration for further analysis.

Under neutral conditions the absorbance spectrum exhibits a single symmetric peak
centered at 330nm for the isolated fluorophore (Figure 3.19). Exciting at that maxima, the
fluorescence is minimal when scanned between 400 and 600nm. When this is repeated in
0.5M NaOH fine structure in the absorbance spectra forms, with a shoulder peak at 330nm
and a main peak that is shifted to 360nm. Again excitation at absorbance maximum results
in the characteristic fluorescence emission at 450nm. Shifting the pH of the solution creates
a fluorescence enhancement of ~68 fold compared to neutral solution (Figure 3.20).
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Quantum yield
While this assay has been used extensively to measure NAD(P)+ concentrations however
it has not been reported how efficient the fluorophore is. In order to do this the quantum
yield (𝛷) was determined for the base product using the standard quinine sulfate. The
absorbance values were then plotted against the fluorescence integral for each of six
concentration points. It was found that the quantum yield for the base product is 0.11 (c.f.
0.54 for quinine sulfate) (Figure 3.20).

Identification of the fluorescent species

Mass spectrometry
The first step in characterizing the unknown fluorophore was to obtain an accurate mass
value for the product. Using freshly prepared and purified material, ESI MS was performed
and provided a molecular ion (MH+) 124.03948 m/z (figure 3.21). A stabile sodiated adduct
(MNa+) at 146.02176 m/z was also found. To ensure that these masses represented the
parent ion and not a daughter fragment, the tube lens voltage was reduced from 120 to 80
V with no appearance of higher mass species. This provided a molecular weight of
123.0315 a.m.u. and a predicted formula of C6H5NO2 with an accuracy of 3.94 ppm.

49

NMR

1

H

The sample was analysed under both neutral and basic conditions by hydrogen NMR. The
sample in water was spiked with D2O to a final concentration of 10% to allow signal lock.
Under these conditions, a singlet is seen at 9.88 ppm consistent with an aldehyde hydrogen.
There are three other resonances seen in the spectrum at 8.18 (dd), 7.81(dd) and 6.63 ppm
(t) (Figure 3.22), consistent with aromatic hydrogens. Upon addition of 1/10th volume of
10M sodium deuteroxide, there was only a slight shift in the resonances. The aldehyde
hydrogen resonance is shifted upfield by 0.01ppm and maintains a singlet structure. The
aromatic hydrogens shift by a small amount, now appearing at 8.08 (dd), 7.83 (dd) and
finally 6.5 ppm (dd) (Figure 3.23). The latter resonance suggests that the triplet seen in the
spectrum of the sample in neutral conditions is likely to be a doublet of doublets with a
symmetrical J coupling value giving the appearance of a triplet.

13

C

Prepared in ammonium acetate and dried under N2. The carbon spectrum of the
isolated fluorophore shows seven peaks. One at 22.95ppm is attributed to the acetate from
preparing the sample. The other six are consistent with one being part of a carbonyl
(192.09ppm) and the five aromatic carbons (180.98, 148.07, 142.77, 124.25 ppm) (Figure
3.24).
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IR
The sample for IR analysis was prepared by extracting the purified material from water
using ethyl acetate. The organic phase was concentrated under N2 gas. The IR spectrum
was collected after drop casting onto the diamond surface and the solvent allowed to
evaporate before collecting (Figure 3.25). No broad peak was seen for the sample in the
region above 3000cm-1 suggesting the absence of any hydroxyl groups in the compound.
There are sharp peaks that dominate the spectrum in the range of 2800-3000 cm-1 which
are likely to correspond to C-H stretches in carbonyl groups. This is supported by strong
peaks at 1690 and 1670 cm-1 consistent with C=O stretching frequencies).
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Discussion

RNA discussion

The first experiments carried out here reported the effects of the G+ modification and the
precursor, preQ0 on the structural stability of tRNA from H. volcanii (HV), M.
thermautotrophicus (MT) and for non-archaeal comparison, E. coli (EC). These species
grow optimally at 45, 85 and 37°C respectively, so the sequences cover moderate and
hyperthermophilic species. It is also notable that H. volcanii is a moderate halophile and
requires around 2.5M NaCl and 1.5M MgCl2 for optimal growth89. This correlates to only
37% of the tRNA sequences from H. volcanii featuring a guanine at position 15 compared
to 60% for M. thermautotrophicus and 100% for T. kodakarensis6, 7.

In vitro melt study
The in vitro prepared
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tRNAs were melted at NaCl concentrations of 100mM. It was

decided to perform the melts in a background of monovalent cations in order to observe
the magnesium specific stabilization of the modified RNA. The background sodium
concentration ensures that the secondary structure and most tertiary contacts should be in
place before the melting begins 52, 57, 90, 91.

At this concentration the in vitro transcribed HVSer tRNA in all three modification states
are identical, with the RNA melting at around 64.4°C. Upon addition of Mg2+ ions the
melting point rises steadily, with the fitted maximal melting temperature being 1°C lower
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than unmodified when preQ0 is present and 0.6°C higher for G+. For the in vitro transcribed
MTGln RNA, modifying the transcript to feature preQ0 and G+ increases the Tm in sodium
by 1.2 and 1.0°C respectively. The high magnesium melting point for unmodified and
preQ0 RNA are identical at 89.7°C. The high magnesium concentration Tm in G+ tRNA is
however raised by 2.1°C. In the in vitro transcribed ECGln RNA all three modification states
have a maximum Tm at high magnesium of 87.3°C. The sodium Tm for both transcript and
G+ are also identical, with the preQ0 being 1°C higher.

The largest change observed in this set of data is in the M. thermautotrophicus sample.
However, even that is only a 2°C increase in the Tm when the G+ modification is in place.
This does not seem a massive shift, especially for a modification that is purported to be
involved in a structural role. However, in previous studies that have examined in vivo
prepared tRNA where all modifications are in place, compared to a unmodified transcript,
a change of 5-6°C is all that is observed92. Individual modifications have been shown to
stabilize active structures (the modification s2T54 in T. thermophilus was found to increase
the Tm by 3°C) active structures and lock in conformations normally under equilibrium that
are conducive for function

93, 94

. The change in Tm observed with G+ formation may be

small, but it is not unusually low compared to other similar experiments with core base
modifications.
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Magnesium binding
The fluorescent chelator HQS has been used in many studies to analyze the observed
affinity of a given RNA for magnesium ions. The experimental technique used here was
devised by the Draper group86, to examine the binding of a tightly coordinated magnesium
ion in the adenine riboswitch. The phenomenon of magnesium being partitioned between
HQS and RNA has been applied to various RNA structures, including tRNA. In 1975 the
yeast tRNAPhe that was the basis for most of the structural information gathered on tRNA
was used in a similar experiment 53.

The results of that study was that the tRNA had two subclasses of magnesium interactions,
a strong interaction with a Kd of approximately 9x104M-1 and a weaker binding mode of
6x103M-1. The occupancy of the two were 19 and 5 ions respectively.

The manual titrations performed using the HQS and the in vitro transcribed M.
thermautotrophicus tRNA showed that there was very little difference between the
magnesium binding displayed by the transcribed tRNAGln, and that of the preQ0 modified
molecule. The binding displayed for the G+ RNA is significantly different to the first two,
but the trend does not correlate to a difference of a singular magnesium ion being lost. At
1mM Mg2+ we observe a decrease in the preferential binding factor 10 ions per RNA
molecule when we compare the G+ modified tRNA to the unmodified transcript. It appears
that the technique used was to insensitive to capture a single loss of a tight binding event.
The number of weakly associated ions swamps out the effects that are seen for other
systems that have more defined binding pockets.
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Growth of TKO mutants
The knockouts of the TGT and ArcS genes from T. kodakarensis gave us the first
opportunity to study the effects of losing the G+ biosynthetic pathway in a
hyperthermophilic archaeon. The cells were confirmed to have maintained the deletion
with PCR confirming the loss of the two genes producing truncated extension products.
Upon harvesting larger quantities of cells it was also possible to confirm loss of preQ0 from
the delTGT and G+ from the delArcS cells by total nucleoside digest of the tRNA. The
RNA was also prepared for accurate mass analysis by ESI LC-MS (performed by the
Limbach group). This further confirmed loss of preQ0 and G+ from the respective cell lines.
This gave us the confidence to go on with the melting studies using these RNAs.

The Santangelo group who originally generated the cell lines had performed growth
experiments (Figure 4.1). This showed that the cells were all able to grow well up to 85°C
(the species normal optimal growth temperature). Although cell density in the deletion cell
lines does not reach that of the wild type, the rate of growth appears comparable in all three.
Raising the temperature to 95°C was found to significantly reduce the growth of both
TK0760 (Dtgt) and TK2156 (DarcS). In large culture the cells grown in house were found
to show significantly reduced growth at 90°C as well. The growth phenotype was seen in
cultures grown on both sulphur or pyruvate (cultures grown in house were on pyruvate
media to allows for easier harvesting of biomass). The phenotype shows that modification
to G+ or apparently even preQ0 assists in the growth of TKO cells at high temperature. This
is in line with the hypothesis we are trying to investigate, in that these modifications may
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be stabilizing tRNA at high temperature, and that their loss, and resultant instability hinders
cell proliferation.

In vivo melts
The first step in approaching the thermal melting experiments was to ensure that we could
obtain the isoacceptor from the total tRNA pool to make a clearer melting profile. The
methodology has been used extensively88 to extract isoacceptors from in vivo prepared
RNA but rarely on a species that grows at such a high temperature. To make sure this was
not going to impede the purification process, test oligos were used along with transcribed
RNA equivalents of the target tRNA. This allowed for the appropriate sequence to be used
that avoided oligomeric high mass particles being formed. This was the case for the oligos
that touched down directly on the most unique stretch of the tRNA sequence. Moving
further to the 3’ of the tRNA sequence permitted the sequestering of the tRNA in to a
discrete complex with the affinity DNA.

The RNA recovered from the affinity tagging (eluted by heating the washed resin at 75°C)
was slow cooled and analyzed by denaturing and native PAGE to confirm both integrity of
the RNA (no laddering in the denaturing gel) and single species being formed by slow
cooling (single band on the native gel). This meant that the RNA was we purified and
appeared to be structurally intact before melting analysis was performed. From 1 litre of
cell culture the yield of isoacceptor was 30µg (WT), 38.4 µg (dTGT) and 35.6 µg (dArcS).
This gave sufficient material for both melting and the above analysis of the same prep.
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The transcribed equivalent of the TKO CUG isoacceptor RNA was modified as in the
experiment with HV, MT and EC tRNA. The melting transitions show a biphasic melting
process, the lower melting occurring at around 65°C which rises to above 70°C at high
magnesium, but persists even at 10mM MgCl2. The second and more substantial melting
point occurs at 85°C at the lowest magnesium concentrations, implying that the TK has a
significantly more stable tRNA compared to the MT RNA. At high magnesium the Tm
cannot be determined as the half point occurs beyond the limit of the experimental
conditions. Very little difference is seen between the three modification states, except that
the unmodified RNA shows a tighter transition for the low Tm than the other two samples.

The in vivo tRNA show a significantly different trend. The WT (G+) and dTGT (G) both
behave almost identically. They both feature two melting transitions, the first, lower Tm at
70°C at low magnesium, but at 100µM the two transitions have merged in to a single event
at 82°C. Increasing the magnesium further raises the Tm to 95°C (1mM) and beyond 98°C
by 10mM. In the dArcS sample which feature preQ0, we observe a lower Tm occurring at
60°C and remaining two phases until 1mM where the collapse in to singular transition at
90. This third RNA is also melting beyond 98°C however a greater proportion of the RNA
is melted at this point seen in the greater dAbs value.

With all the other modifications in place, no significant increase in the Tm of the tRNA is
produced. However, given the inherently more stable sequence, we are already melting at
higher temperatures than in the other RNAs in this study. The pattern of response to
magnesium is similar that seen in the E. coli tRNAPhe in comparing in vivo matured vs in
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vitro material95. The change in Tm at biologically relevant ionic concentrations are not
massively different, but there are clear differences in how components of the folding
process respond at different modification states.

Given that we do not see a significant loss of thermal stability at conditions equivalent to
growth conditions, and yet we see a growth phenotype at higher temperature, the results
may seem to be at odds. However, that assumes that the loss of viability of the cell lines at
high temp is simply due to reduction of absolute melting point.

The original hypothesis for the function of archaeosine was that it took on a structural role
to stabilize tRNA in thermophilic archaeal species. This is born out in the in vitro prepared
tRNAGln from M. thermautotrophicus, where a 2.1°C increase in melting point was
measured when archaeosine was present. This was not reproduced in the tRNA of fellow
extreme thermophile T. kodakarensis, moderate thermophile H. volcanii or the bacterium
E. coli, this would suggest that the effects of G+ modification are dependent on the RNA
in which it occurs and possibly the species in which it is being formed. Indeed, in the
context of in vivo maturated tRNA with all modifications are steady state levels except for
preQ0 or G+, we see that G+ modification confers no additional stabilization beyond the
genetically encoded guanine base. Somewhat surprisingly, in vivo material with preQ0
present, is actually less stable that the genetically encoded guanine. This creates the
possibility of a more complicated structural consequence of the G+ pathway, one that is
dependent on the species, it’s tRNA primary sequence and environmental conditions for
the role that G+ ultimately serves.
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Previously, similar studies have found that loss of a given modification doesn’t always
produce a significant change in overall thermal stability, but increased dynamics of the
RNA makes it less functional at higher temperatures. Loss of m7G at position 46 by a
deletion of the methyltransferase trm8 in yeast caused reduced modification at other sites96.
There was a temperature dependent growth response, where cell taken from 28°C to 37°C
showed reduced growth. Analysis of the tRNA stability showed little difference in the
stability of the tRNA, but increased dynamics of the RNA meant that subsequent
modifications were not being produced. This led to the specific degradation of tRNA valine
(other tRNAs normally featured the modification but were not degraded). This first
instance of Rapid tRNA Decay (RTD) pathway for the targeted removal of misfolded
tRNA showed that the observed temperature dependent growth phenotype might not be
directly related to RNA stability but to the modification status of the tRNA.

Similarly, loss of a single pseudouridine at position 55 in T. thermophilus was found to
have a significantly higher Tm (8.4°C) if it was grown at low temperatures. It was proposed
that loss of Y55 actually increased the amount of other stabilizing modifications which
made for a more rigid structure. This then in turn, decreased its ability to function in the
cell giving a growth phenotype at low temperatures caused by an overly stable, misfolded
RNA97. The degradation of tRNA by a bacterial RTD was also first identified in T.
thermophilus28.

There is still a dearth of information regarding the function of base modifications that occur
in the core region of tRNA (Figure 4.2). One of the most abundant of these modifications
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are methylations. Though some of these are specific to the archaea, there is often a parallel
modification that occurs in the other domains, serving a similar role. Methylation events
are often involved in directing the formation of hydrogen bonding at the core. In P. abysii
for example, m22G10 creates steric hindrance that directs the formation of the D-stem, in
the case of tRNAPro, by enhancing a wobble base pairing with U25, and in tRNAAsp, by
preventing a 2 base slip that causes the D-loop to be expanded98. In H. volcanii the same
modification regulates the formation of the AC stem in prolyl tRNA by a similar
mechanism99. In the region between the accepter stem and the variable loop, position 48
and 49 will often be methylated (m5C) but in this case, it is believed that the modifications
are acting to enhance base pairing by shifting the electronics of the modified bases.

In archaea specifically, further modification of these methylated bases can occur where Omethylation at the 2’OH of the ribose takes place. The gradual addition of methyl groups
has been shown to be an adaptive response to increasing growth temperatures100. The
population of m22Gm goes up as the precursor m22G decreases (60-70% of the precursor is
converted to the O-methyl derivative at the highest growth temperatures used).

Uridine is also commonly modified in the core, and the modifications are also sensitive to
sequence and growth conditions. Pseudouridinylation will occur at position 13, stabilizing
base pairing between itself and position 22 which forms in the D stem. It is only modified
however if the base at position 22 is a U or G, canonical base pairing to A22 does not
induce the modification to be carried out. The occurrence of pseudouridine in the T-loop
is well known, acting as one of the bases (Y55) that creates loop-loop interactions with the
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D-loop. In archaea, the position 54 is also found to be modified to Y, m1Y and also the
related high temperature induced m5s2U. These modifications help to ensure the correct
structure is adopted in the T-loop to maintain needed tertiary contacts.

Crystalographic studies have shown that arcTGT binds to tRNA in an alternative l-form
structure 101 where the D-stemloop is fully disrupted, allowing the enzyme to “count” the
first 15 bases of the substrate. Indeed, biochemical characterization of the P. horikoshii
enzyme showed that the enzyme became increasingly active the higher the temperature of
the exchange reaction was carried out at (up to 100°C)44. It is possible that the addition of
preQ0 to a new transcript will occur fairly early in the maturation process. If the disordered
RNA needed for TGT activity is to be funneled in to an active form for further modification
and function, it is possible that the G-preQ0-G+ status at position 15 serves as a check point
for viability of the tRNA. Since the more extreme halophiles are able to thrive with a lower
number of their tRNA featuring the modification, it is possible that preQ0 and G+
modifications help direct the maturation process or the folding of extended transcript in to
functional tRNA.

Synthetase charging assays would give an immediate answer as to the functionality of the
in vivo produced tRNAs. Looking at the folding rates of tRNA in the same, stepwise
modification status as has been carried out in this study, would be the likely next step to
see if the role of G+ lies in the direction of the folding pathway, rather than the stabilization
of an already folded tRNA.
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Identification and characterization of NAD(P)+ base product

The continued use of the methodology established in the 1950s 102 shows it to be rigorous
and flexible enough to still be of use to current research of systems consuming NAD(P).
The exact nature and properties of the fluorophore however have been largely ignored since
the protocol is so reliable. Here we have characterized the fluorophore to be 2-hydroxynicotinaldehyde.

Identification of the fluorophore

Isolated immediately from the assay work up conditions, the first step in determining the
structure was recording an accurate mass. Since no mass higher than the mono-sodium
adduct of the product species was found, it put an immediate bracket on the structures
possible. The strong signal and accurate mass obtain in positive mode ESI meant that we
could be confident in the molecular mass of 123.0315 g/mol. This allowed the formula to
be calculated at C6H5NO2.

In order to confirm this, the fluorescent product needed to be characterized
spectroscopically to identify structural features to finalize the structure. In order to collect
the NMR spectra the product was collected by HPLC in MQ water. From here it was
initially attempted to dry down under vacuum to remove the water, however it was found
that the product was volatile. Under the vacuum supplied by a speedvac (30 in Hg below
ambient) all material volatilized and so could not be recovered. To provide more gentle
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drying conditions, the sample was concentrated under nitrogen. After significant
concentration, the sample, still in aqueous solution was spiked with deuterium oxide for
signal locking. Since there was still such a strong residual water signal, the H1 spectra were
recorded using a water suppression pulse sequence. Under these conditions, four protons
were recorded. This would suggest that there is one exchangeable proton given the
predicted formula. The resonances and splitting pattern suggested an aldehyde proton at
9.88 ppm that showed no coupling. The remaining three protons are 8.18, 7.81 and 6.63
ppm. These are characteristic for aromatic protons, so it is highly likely that we have an
intact ring structure. This is supported by the C13 spectrum which suggests 5 aromatic
carbon centers and an aldehyde resonance.

The three ring protons are in three distinct environments, and so it is likely that the ring
structure is asymmetrically substituted. The observed resonances for the a (8.18), b (6.63)
and g (7.81) match the deshielding pattern of pyridine. The splitting patterns for the three
protons in water are also in support of this with the constants being a (Jb = 7.27 Hz, Jg =
2.19 Hz), b (Ja,g = 6.83 Hz) and g (Ja = 2.20 Hz, Jb = 6.32).

Maintenance of the pyridine ring, along with the formation of a formyl group leaves an
oxygen and a fifth proton left to be accounted for based on the MS derived formula. The
proton for a hydroxyl group would be exchangeable and so not seen in the proton NMR.
Performing a N15-H1 coupled HSQC experiment (data not presented) on the sample also
hinted that the nitrogen was not stably protonated as no signal was detected for protons
excited by resonance to the only nitrogen atom. Using spectrum prediction software, the
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theoretical spectra for the 2-hydroxy derivative rather than the 3-hydroxy most closely
matches the pattern seen empirically 103, 104. Although the simulations are calculated based
on DMSO as the solvent, the observed resonances and splitting pattern can again give us
confidence in our structural assignments.

Once the identity of the product was confirmed, literature searches for 2hydroxynicotinaldehyde (2HNA) brought up hits from the early 1970s where analogs of
NAD+ were studied to investigate the fluorophore first identified by Kaplan in 1951.
Comparison of pyridinium and nicotinamide derivatives showed that the carboxamide
substitution at position 3 is able to significantly enhance the susceptibility of such
molecules to nucleophilic attack at position 2. Indeed, the formation of the 2-hydroxy
derivative in nictotimamides are found to have a rate ~1000 fold higher than that of the
pyridinium equivalent. This in turn translates in to a Keq enhancement of 6000 fold for the
formation of the open ring form of the two families105-107.

Guilbert and Johnson

108

carried out the base work up on 1-(N,N-dimethylcarbamoyl)

nicotinamide chloride and diphosphopyridine nucleotide (DPN). They were able to
characterize the product of the reaction between these two analogs as being identical to
2HNA and synthesized a control of the substance for full comparison.

Using the dimethylcarbamoyl analog the mechanism of formation was deduced for 2HNA.
Initial base treatment of a species featuring an oxidized nicotinamide moiety produced
what is referred to as the open ring form of NAD (ONAD). The conversion from ONAD
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to 2HNA goes through a second major intermediate that is created upon hydrolysis of the
Schiff base form of ONAD. This would release everything connected to what was
previously

the

ring

nitrogen

of

the

nicotinamide,

leaving

2-carboxamide-

glutacondialdehyde (CGDA).

Recyclization occurs upon deprotonation of CGDA which facilitates nucleophilic attack of
the amide nitrogen upon carbon 5. This regenerates the pyridine structure and upon further
decomposition generates 2-HNA109. The overall mechanism deduced for the generation of
2-HNA from oxidized nicotinamide species is laid out in (Figure 4.3) with key
intermediates in the process highlighted. There are secondary reactions at most steps,
however the concentration of base used really drives the process to the overall yield of
around 95%.

The work up condition specified in the original methodology paper by Lowry et al. exposed
the biological sample to 8N NaOH in order to generate the fluorogenic species detected in
the assay. With the knowledge gleamed from previous studies and now this one, it would
appear that this is far more aggressive than it need be. The early work was carried out on
pyridine derivatives and then transferred to the nicotinamide nucleotides as an application
to biological systems. The studies by Johnson throughout the 70s showed that the
nicotinamide moieties were faster to react, and also more sensitive to base concentration
to produce the ring opening derivatization105.
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Unlike the pyrimidine system which achieves maximum yields of fluorescence at pH > 13,
the equivalent effects can be generated at up to four pH units below this with nicotinamides.
In the time courses completed in this study it was shown that fluorescence can be recorded
maximally when incubated at 2M NaOH. The reaction time of 2 hours is also more than
enough for all NAD(P)+ to be converted to the 2-HNA. As long as the reaction has been
successfully quenched in the 150mM HCl step, incubation in 2M base should still provide
a significant excess of hydroxide ion concentration to fully convert to 2-HNA. Indeed, the
lower base concentration may be of benefit by making the assay conditions more product
stable over a prolonged time. Since the chemistry to generate 2-HNA permits going to
completion at lower concentrations and is not under equilibrium, the reduced fluorescence
observed at higher concentrations may be resulting from decomposition of the target
molecule. This considered it may be advisable to reduce the concentration of NaOH used
to 2-3 M to permit an increased dynamic range and stability of sample.
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Tables
Table 1 Sequences of tRNA used in initial thermal stability experiments. H. volcanii
SerCGA, M. thermautotrophicus GlnUUG and E. coli GlnUUG tRNA sequences. The RNAs
are transcribed from templates produced by Klenow extension of the corresponding DNA
oligo pairs. The DNA primers add the T7 promoter sequence (bold) and the annealing
overlap is shown underlined.
RNA sequences
Ser CGA (H. volcanii)
5’GCCGAGGUAGCCUAGCCCGGCCAAGGCGGUAGAUUCGAAAUCUACUGUCCAUUCGGACACGUG
AGUUCAAAUCUCACCCUCGGCG3’
Gln UUG (Methanothermobacter thermautotrophicus)
5’AGUCCCGUGGGGUAGUGGUAAUCCUGCUGGGCUUUGGACCCGGCGACAGCGGUUCGACUCCGC
UCGGGACUAUCA3’
Gln UUG (E. coli)
5’UGGGGUAUCGCCAAGCGGUAAGGCACCGGUUUUUGAUACCGGCAUUCCCUGGUUCGAAUCCAG
GUACCCCAGCCA3’
Klenow template sequences
Ser CGA (H. volcanii)
5’GCAGTAATACGACTCACTATAGCCGAGGTAGCCTAGCCCGGCCAAGGCGGTAGATTCGAA3’
5’TGGCGCCGAGGGTGAGATTTGAACTCACGTGTCCGAATGGACAGTAGATTTCGAATCTAC3’
Gln UUG (Methanothermobacter thermautotrophicus)
5’GCAGTAATACGACTCACTATAAGTCCCGTGGGGTAGTGGTAATCCTGCTGGGCTTG3’
5’TGGTAGTCCCGAGCGGAGTCGAACCGCTGTCGCCGGGTCCAAAGCCCAGC3’
Gln UUG (E. coli)
5’GCAGTAATACGACTCACTATAAGGGGTATCGCCAAGCGGTAAGGCACCGGTT3’
5’TGGCAGGGGTACCTGGATTCGAACCAGGGAATGCCGGTATCAAAAAACCGGTGC3’
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Table 2 Sequences of tRNA used in TKO in vitro melting study. The RNA sequence that
was used is shown first, below are the DNA oligos used to generate double stranded
template for in vitro transcription.
RNA sequence
Gln CUG (Thermococcus kodakarenisis)
5’AGCCCCGUGGUGUAGCGGCCAAGCAUGCGGGACUCUGGAUCCCGCGACCGGGGUUCGAAUCCC
CGCGGGGCUACCA3’

Klenow template sequences
5’TAATACGACTCACTATAGGCCCCGTGGTGTAGCGGCCAAGCATGCGGGA3’
5’mUmGGTAGCCCCGCGGGGATTCGAACCCCGGTCGCGGGATCCAGAGTCCCGCATGC3’
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Figures
Figure 1.1 Structure of tRNA(a) Secondary structure of a typical tRNA shown in the
cloverleaf representation. (b) The folded structure of the active tRNAPhe from S.
cerevisiae (PDB accession 1EHZ).
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Figure 1.2 Naturally occurring modified bases. Naturally occurring modified nucleotides
which are all found in tRNAs. Both queuosine and N6-threonylcarbamoyl adenine are
located at the anticodon loop and maintain translation fidelity. 2’-O-methylcytidine and
N7-methylguanine are involved in structural stability. Modified functional groups are
shown in blue.
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Figure 1.3 Biosynthesis of preQ0 nucleobase. The first steps that are common to the
archaeosine and queuosine pathway is the formation of preQ0 from GTP. Figure modified
from Biochemistry 2009, 48, 3847-3852.
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Figure 1.4 Queuosine biosynthesis. The fate of preQ0 in bacteria is to be converted to
preQ1 before being inserted in to tRNA by bacTGT. Figure modified from NAR. 2016,
44(20): 9965–9976
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Figure 1.5 Archaeosine (G+) biosynthesis. After insertion in to substrate tRNA at position
15, preQ0-tRNA is further modified by either ArcS (A), QueF-like (Q) or Gat-QueC (G).
(ACS Chem Biol. 2012; 7(2): 300–305)
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Figure 1.6 Electron density computed for Guanine and modeled G+. The model proposes
a substitution of a coordinated magnesium ion in unmodified tRNA for the positively
charged formamidino group of G+ (RNA. 2007 Sep; 13(9): 1427–1436).
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Figure 1.7 The positioning of Mg2+ and Mn2+ in the proximity of N7 in guanine 15. The
crystal structure of tRNAPhe from S. cerevisiae showing the unmodified Levit base pair
(G15-C48) in stick mode. The neighboring nucleotides are shown in surface render
indicating negatively charged phosphates (orange and red) surrounding the manganese ion
(purple sphere).
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Figure 1.8 Thermal melting of tRNA structure. Using the hyperchromic effect of UV
absorbance during thermal denaturation of tRNA it is possible to detect the unfolding
events as subpopulations in the melting profile (first differential plot of dAbs vs T). (a) the
melting of in vitro and in vivo tRNAPhe in EDTA (dotted), 100µM MgCl2 (solid) and
4mM MgCl2 (dashed) (NAR 1998 Jun 1; 26(11): 2723–2728). Subpopulations shown as
peaks I or II have been previously deconvoluted by NMR studies to represent individual
structures falling apart. (b) the subpopulations are sensitive to the concentration of
magnesium ions and at biologically relevant concentrations the melting of tRNA collapses
into a single melting event dictated by the breaking of the D-stem/T-stem contacts. (Trends
Biochem Sci. 1996 Apr;21(4):145-9).
(a)

(b)
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Figure 1.9 The de novo synthesis and salvage pathways of NADH. Schematic for the
biosynthetic pathway of both NAD and ultimately NADP cofactors. (FEBS Journal, 2012,
279, 3355-3363)
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Figure 3.1 SDS PAGE analysis of arcTGT purification. CFE is the total soluble protein
fraction and RT is the run through fraction that does not interact with the resin. Unbound
and non-specifically bound proteins are eluted at 0 and 10mM imidazole respectively. The
target 6His fusion protein is eluted at 50mM imidazole.
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Figure 3.2 SDS PAGE analysis of ArcS purification. SN is the total soluble protein fraction
obtained following lysis and RT is the run through fraction that does not interact with the
resin. A stepwise gradient of imidazole concentration was applied and the target ArcS was
eluted at 50mM imidazole.
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Figure 3.3 Modification of the in vitro prepared tRNA. (a) shows the [8-14C-guanine]
incorporation into substrate tRNA to assay arcTGT activity. (b) HPLC separation of total
nucleoside digest of preQ0 modified tRNA, with the modified nucleoside eluting at
approximately 21.5 minutes. (c) transformation of preQ0 (black) in to G+ (gray) by the
activity of ArcS, again showing total nucleoside digest analysis by RP-HPLC.
(a)

(b)
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(c)
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Figure 3.4 Magnesium dependence of thermal stability of tRNA. The in vitro transcribed
tRNA for (a) H. volcanii, (b) M. thermautotrophicus and (c) E. coli have been modified to
feature preQ0 or G+. The RNA is melted under increasing concentrations of Mg2+ ions in a
background of 100mM NaCl. The isotherms are fitted to a two-state model to obtain
minimal and maximal melting temperatures.
(a)

(b)
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(c)
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Figure 3.5 Magnesium dependence of thermal stability of tRNA. The extracted values for
the isotherm fits of magnesium dependence on Tm. For each RNA species and modification
state there is a minimum and maximum Tm and the transition midpoint for the response.
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Figure 3.6 Magnesium binding by fluorescence of HQS. (a) Preparation of the
demetallated HQS reagent by recrystalization gives a magnesium responsive fluorophore
whose absorbance spectra have well defined isosbestic points. (b) Binding of magnesium
in the absence (red) and presence of trx (dark blue) and G+ (light blue) tRNA gives an
observed shift in the affinity of magnesium for the dye. (c) The difference between the
control titration (HQS alone) and the RNA titration is used to deduce the preferential
binding coefficient (colored as previous figure).
(a)

(b)
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(c)
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Figure 3.7 Scheme for the generation of arcTGT (TK0760). The addition of the TK0149
to the knockout cassette permits temporary prototrophism to be established in the normally
agmatine auxotrophic TKO strain. The gene for 6-methylpurine (6MP) acts as a counter
selective agent to drive the looping out of the cassette to produce the final stable TK0760
cell line.
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Figure 3.8 Confirmation of knockout in TKO cell line by PCR. Genomic material was
recovered from each cell line and amplified by PCR, targeting either the TGT gene cassette
(lanes 1, 2 and 3) or the ArcS gene cassette (lanes 4, 5 and 6). Lanes 1 and 4 confirm WT
maintains both genes. Lanes 2 and 6 confirm the TGT and ArcS, respectively, have been
successfully knockdown with truncation of the cassette. ArcS is still present in the ∆tgt
cells and TGT is still present in ∆arcS.
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Figure 3.9 Analysis of purified total in vivo tRNA. (a) Denaturing PAGE separation of the
tRNA pool extracted from the three cells lines. 1 & 2 are WT LiCl precipitation products,
3 &4 ∆tgt and 5 & 6 are ∆arcS. (b) Total nucleoside digest of the samples analyzed by RPHPLC. PreQ0 appears at 26 minutes and is absent from the WT and ∆arcS samples. G+
elutes at 30 minutes and is present in the wild type sample only.
(a)

(b)
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Figure 3.10 Mass spectrometry of the in vivo modified tRNA. The extracted
chromatogram for G+ (324+H+) are shown for each cell line tRNA sample. (a) The WT
shows a strong peak at 29 minutes corresponding to the G+ nucleoside. (b) In the TGT
knockout, no peak is seen for this mass confirming the expected effect. (c) In the Arcs
knockout, there is a peak at approximately 1.6% of the WT intensity seen.
(a)

(b)

(c)
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Figure 3.11 Affinity tag for isolation of GlnX isoacceptor from TKO. (a) The target
sequences of the GlnX gene that were used to derive affinity oligos (the reverse
compliment of sequence shown). (b) Native PAGE analysis of the complexes formed
between the four candidate oligos and the transcribed tRNACUG.
(a)

(b)
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Figure 3.12 Purification of the GlnX isoacceptors. Total tRNA from the three cell lines
was incubated with streptavidin sepharose which had been coupled with the biotinylated
Aff3 oligo. The RNA (in 10mM Tris.HCl pH 7.0, 900mM NaCl and 1mM EDTA) was
heated to 95ºC and mixed with pre-equilibrated resin. The suspension was slow cooled to
allow the Aff3 to anneal to the tRNA. The wash fractions (W) of annealing buffer were
continued until the OD260 was below 0.001 units. The RNA was eluted at both 45 and 75ºC
in 10 mM Tris.HCl pH 7 and 100mM NaCl.
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Figure 3.13 Confirmation of in vivo isoacceptor purity. The isoacceptors were slow cooled
according the melt experiment prep and then run through either a 10% denaturing PAGE
(a) or an 8% native gel (b). Lane 1: mixture of tRNACUG (76mer) and a DNA oligo at 49
bases (d49) and 19 bases (d19) in length. Lane 2: WT, lane 3: ∆tgt and lane 4: ∆arcS.
Xylene cyanol (XC) and bromophenol blue (BB) are shown for electrophoretic progress.
(a)

(b)
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Figure 3.14 Melting profiles of in vitro produced TKO GlnCUG. The GlnCUG sequence was
used for comparison to the in vivo material extracted from T. kodakarensis. The RNA was
modified in vitro to produce G (black), preQ0 (dashed) or G+ (gray) at position 15. The
melting profiles were recorded at (a) 100mM NaCl (b) 1µM MgCl2 (c) 100µM MgCl2 and
(d) 10mM MgC12.
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Figure 3.15 Melt profiles of in vivo TKO GlnX isoacceptor tRNA. The purified isoacceptor
tRNA from WT (black), ∆tgt (dashed) and ∆arcS (gray) are melted in the presence of
increasing Mg2+ concentrations; (a) 100mM NaCl, (b) 10µM MgCl2 (c) 100µM MgCl2 (d)
1mM MgCl2 (e) 10mM MgCl2.
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Figure 3.16 The products of acid treatment of reduced NADPH. (a) HPLC separation of
NAPDH in water (red) and following treatment with 150mM HCl (blue). HPLC was
carried out using an isocratic mobile phase of 100mM NH4OAc (pH 6.8). (b) The extracted
absorbance spectrum (red) for the peak at 3.3 minutes of the untreated NADPH separation.
The product peaks for the adenosyl moiety (dashed blue) and nicotinamide moiety (solid
blue) eluting at around 0.5 and 6.5 minutes respectively.
(a)

(b)
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Figure 3.17 Time dependence of fluorophore yield. (a) Fluorescence intensity of a solution
of NADP+ and increasing concentration of NaOH. Immediate quantitation of fluorescence
is in red, the blue data points reflect an 18hr incubation at each concentration. (b) HPLC
separation of the base treatment of NADP+ at 2M NaOH. The NADP+ is shown in red.
Immediate quenching with HCl produced the products for 0 mins (blue dash), 60 minutes
(blue dotted) and 120 minutes (solid blue). The loss of NADP+ 260nm absorbance is shown
inset.
(a)

(b)
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Figure 3.18 UV spectra of NADPH, NADP+ and NMN derivatives. (a) NADPH in water
(dark blue), treated with base in 0.5M NaOH (medium blue) and in water (light blue). (b)
NADP+ in water (purple), treated with base in 0.5M NaOH (lilac) and in water (magenta).
(c) NMN in water (red), treated with base in 0.5M NaOH (yellow) and in water (orange).
Base treatment in each case was 2hr in 2M NaOH before being neutralized with HCl.
(a)

(b)

(c)
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Figure 3.19 UV absorbance and fluorescence of isolated fluorophore product. The
absorbance spectrum of the product was measured between 250 and 500nm, in both neutral
conditions in water (red) and 0.5M NaOH (blue). The fluorescence is measured from 400
to 600nm with excitation at 360nm (dashed lines, colors represent the same conditions as
absorbance).
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Figure 3.20 Determination of quantum yield for the base product. The fluorescence spectra
of a quinine sulfate standard (red) in 0.5M H2S04 and the base product (blue) in 0.5M
NaOH. The area between 400 and 600 nm was integrated and plotted against the
corresponding absorbance value at 350nm.
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Figure 3.21 Accurate mass determination. Freshly prepared and purified fluorophore in DI
water is mixed with an equal volume of methanol before being analyzed by electrospray
MS. In positive mode the two main peaks have m/z of 124.03948 and 146.02178. This
corresponds to a molecular weight of 123.0315 gmol-1.
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Figure 3.22 1H NMR of the isolated fluorescent product. Water suppression 1H spectrum
of the HPLC purified product shows four resonances: 9.88 (s), 8.18 (d,d), 7.81 (d) and 6.63
(t) (expanded in lower panels). Spectrum collected in 10% D2O.
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Figure 3.23 1H NMR of the isolated fluorescent product in basic conditions. Water
suppression 1H spectraum of the HPLC purified product shows four resonances: 9.87 (s),
8.08 (d,d), 7.83 (d,d) and 6.50 (d,d) (expanded in lower panels). Spectrum collected in 1M
NaOD.
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Figure 3.24 13C NMR of the isolated fluorescent product. Carbon spectrum of the HPLC
purified product shows seven resonances: 192.09 (s), 180.98 (s), 148.07 (s), 142.77 (s),
124.25 (s) and 108.47 (s) relate to the compound being studied. The resonance at 22.95
ppm is from the acetate carried over from the purification.
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Figure 3.26 IR spectrum of the isolated fluorophore. The sample was extracted from the
MQ water with ethyl acetate and concentrated under nitrogen.
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Figure 4.1 Growth phenotype of the T. kodakarensis mutants. Both the Dtgt (TK0760) and
DarcS (TK2156) mutants show greatly reduced growth at 95° where the wild type is still
showing rigorous growth.
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Figure 4.2 Location of base modifications in the core of tRNA. Shown is a schematic of
the tRNA form H. volcanii, showing type and location of modifications that are specific to
Archaea and facilitate the formation of the folded core (bases in the blue box). (figure
modified from BMC Genomics, 2008, 9:470).
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Figure 4.3 Mechanism of base reaction to yield 2-hydroxynicotinaldehyde. The first step
in producing 2HNA is the nucleophilic attack of hydroxide at position 2 of a reduced
nicotinamide species (i). This yields (ii) which upon further supply of hydroxide ions
irreversibly is converted to the ring open form of NAD+ or ONAD (iii). This decomposes
to generate 2-carboxamideglutacondialdehyde (CGDA) (iv) with loss of what was the ring
nitrogen of the starting material. Intramolecular re-cyclization results in the formation of
the fluorescent product (v) which is in equilibrium with the inactive protonated form (vi).
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